Western Australian BiotechnologyIndustry DirectoryJune 2003

PRODUCED BY:

Bio Industries BranchDepartment of Industry and ResourcesDumas House2 Havelock StreetWest Perth WA 6005Tel: (+61 8) 9222 5555Fax: (+61 8) 9222 5055Web: www.doir.wa.gov.au

June 2003

With the support and assistance of Ausbiotech (WA), WesternAustralian Department of Agriculture, State AgriculturalBiotechnology Centre and the CSIRO.

DISCLAIMER:

Whilst every care has been taken in compiling the informationin the Western Australian Biotechnology Industry Directory, theDepartment of Industry and Resources and its contractorsneither warrant nor represent that the material published hereinis accurate or free from errors or omissions. To the extentpermissible by law, the Department of Industry and Resourcesand its contractors shall not be responsible or liable for anyerrors, omissions or misrepresentations made herein.

1

Contents

Introduction ......................................................................................................................................... 5

Company Listings by Category ................................................................................................... 7 - 45

AgritechnologiesAg-Id Pty Ltd .............................................................................................................................................................7Agri-BIOTECH Pty Ltd ..............................................................................................................................................7AquaCarotene Limited .............................................................................................................................................8Artemia Biotechnology Centre Pty Ltd ...................................................................................................................... 9BioEnergy Australia Pty Ltd ................................................................................................................................... 11Bio-Gene Technology Pty Ltd ................................................................................................................................. 11Biomedical Investments Ltd .................................................................................................................................. 36Biorex Health Ltd ................................................................................................................................................. 12Botanic Gardens and Parks Authority (Kings Park) ............................................................................................. 12Centre for High-throughput Agricultural Genetic Analysis (CHAGA) ................................................................... 13CRC for Legumes in Mediterranean Agriculture (CLIMA) .................................................................................... 15CSIRO - Centre for Mediterranean Agricultural Research ................................................................................... 16CSIRO - Livestock Industries - Mediterranean Livestock Systems (MLS) ........................................................... 16Curtin University - Department of Environmental Biology .................................................................................... 17Department of Agriculture ..................................................................................................................................... 18FOSS Pacific Pty Ltd ............................................................................................................................................. 21Grain Biotech Australia Pty Ltd ............................................................................................................................. 22ID + Plus Ltd .......................................................................................................................................................... 22The Oil Mallee Company of Australia Ltd ............................................................................................................. 42Saturn Biotech Ltd ................................................................................................................................................. 29

BioEngineeringLions Ear and Hearing Institute ............................................................................................................................ 24Murdoch University Biotechnology Program ........................................................................................................ 25Ozgene Pty Ltd ...................................................................................................................................................... 25Phylogica Ltd ......................................................................................................................................................... 27pSivida Ltd ............................................................................................................................................................. 28

BioinformaticsBiomedical Investments Ltd .................................................................................................................................. 36Centre for Bioinformatics and Biological Computing ............................................................................................ 13Lions Ear and Hearing Institute ............................................................................................................................ 24

Devices, Instrumentation and EquipmentArgus Biomedical Pty Ltd ........................................................................................................................................ 9Biomedical Investments Ltd .................................................................................................................................. 36Eastland Medical Systems Limited ....................................................................................................................... 19ENT Technologies Pty Ltd ..................................................................................................................................... 19Gray Surgical ......................................................................................................................................................... 22Lions Ear and Hearing Institute ............................................................................................................................ 24Perth Bone and Tissue Bank Inc. ......................................................................................................................... 27VibraQ Corporation ............................................................................................................................................... 33Xcell Diagnostics ................................................................................................................................................... 35

Diagnostic ProductsFisher Biotec Pty Ltd ............................................................................................................................................. 20Inner Vision Biometrics Pty Ltd ............................................................................................................................. 22Paradigm Diagnostics ........................................................................................................................................... 26Rockeby Biomed Limited ...................................................................................................................................... 28University of Western Australia, Office of Industry and Innovation ...................................................................... 31Xcell Diagnostics ................................................................................................................................................... 35

Diagnostic Services (human)DNA-ID Labs Pty Ltd ............................................................................................................................................. 18In Vitro Laboratories Pty Ltd ................................................................................................................................. 22pSivida Ltd ............................................................................................................................................................. 28Uropath Pty Ltd & Tissugen Pty Ltd ...................................................................................................................... 32

2

Environmental technologiesAquabiotics Pty Ltd .................................................................................................................................................. 8Artemia Biotechnology Centre Pty Ltd .................................................................................................................... 9AtSource Organics Australia Pty Ltd .................................................................................................................... 36Australian Institute of Marine Science (AIMS) ...................................................................................................... 10Bactech (Australia) Pty Ltd .....................................................................................................................................11Biomax Pty Ltd ...................................................................................................................................................... 12Biomedical Investments Ltd .................................................................................................................................. 36BioProspect Ltd ..................................................................................................................................................... 12Botanic Gardens and Parks Authority (Kings Park) ............................................................................................. 12CSIRO Land and Water ........................................................................................................................................ 16CSIRO - Livestock Industries - Mediterranean Livestock Systems (MLS) .......................................................... 16CSIRO Minerals - AJ Parker CRC for Hydrometallurgy ....................................................................................... 17Environmental Solutions International Ltd ............................................................................................................ 19Integra Management Pty Ltd ................................................................................................................................. 23Mount Todd Rehabilitation Project Pty Ltd ............................................................................................................ 25The Oil Mallee Company of Australia Ltd ............................................................................................................. 42Pacific Ore Technologies Australia Pty Ltd ........................................................................................................... 26Peko Rehabilitation Project Pty Ltd ...................................................................................................................... 26Talon Resources .................................................................................................................................................... 30Titan Resources NL ............................................................................................................................................... 30World Waste Solutions .......................................................................................................................................... 35

Food & beverage technologiesBio-Gene Technology Pty Ltd .................................................................................................................................11CSIRO - Livestock Industries - Mediterranean Livestock Systems (MLS) .......................................................... 16

HealthCareAsthma & Allergy Research Institute Inc ................................................................................................................ 9Keogh Institute for Medical Research ................................................................................................................... 23Kestral Computing ................................................................................................................................................. 23Perth Bone and Tissue Bank Inc. ......................................................................................................................... 27University of Western Australia, Office of Industry and Innovation ...................................................................... 31

InstrumentationFluid System Technologies (WA) .......................................................................................................................... 20FOSS Pacific Pty Ltd ............................................................................................................................................. 21

Research & Development Service ProviderAsthma & Allergy Research Institute Inc ................................................................................................................ 9Australian Neuromuscular Research Institute ...................................................................................................... 10Australian Research Centre for Medical Engineering ...........................................................................................11Botanic Gardens and Parks Authority (Kings Park) ............................................................................................. 12Canola Breeders Western Australia Pty Ltd ......................................................................................................... 12Centre for High-throughput Agricultural Genetic Analysis (CHAGA) ................................................................... 13Centre for Human Genetics .................................................................................................................................. 13Centre for Microscopy and Microanalysis ............................................................................................................. 14Centre for Molecular Immunology & Instrumentation ........................................................................................... 14Chemistry Centre (WA) ......................................................................................................................................... 14CSIRO.................................................................................................................................................................... 15CSIRO - Centre for Mediterranean Agricultural Research ................................................................................... 16CSIRO - Land and Water ...................................................................................................................................... 16CSIRO - Livestock Industries - Mediterranean Livestock Systems (MLS) ........................................................... 16CSIRO Minerals - AJ Parker CRC for Hydrometallurgy ....................................................................................... 17Curtin University - School of Biomedical Science ................................................................................................ 18Paradigm Diagnostics ........................................................................................................................................... 26Proteomics International ....................................................................................................................................... 27Telethon Institute for Child Health Research ........................................................................................................ 30University of Western Australia, Office of Industry and Innovation ...................................................................... 31University of Western Australia - School of Electrical, Electronic and Computer Engineering - Optical and BiomedicalEngineering Laboratory ......................................................................................................................................... 32Western Australian Biomedical Research Institute .............................................................................................. 34Western Australian Institute for Medical Research .............................................................................................. 34Women and Infants Research Foundation ........................................................................................................... 35

3

Retail and Wholesale SuppliersAdvanced Nano Technologies Pty Ltd .................................................................................................................... 7Australian Biosearch ............................................................................................................................................... 9Canola Breeders Western Australia Pty Ltd ......................................................................................................... 12Cottman SBA ......................................................................................................................................................... 15Fluid System Technologies (WA) .......................................................................................................................... 20Gene Stream Pty Ltd ............................................................................................................................................. 21Ibis Technology ...................................................................................................................................................... 22Lawley Pharmaceuticals Pty Ltd ........................................................................................................................... 23

Technical Service Provider and ProductsArtemia Biotechnology Centre Pty Ltd .................................................................................................................... 9Centre for Bioinformatics and Biological Computing ............................................................................................ 13Paradigm Diagnostics ........................................................................................................................................... 26Tri-Med Distributors Pty Ltd ................................................................................................................................... 30

Therapeutics (human)Alzhyme (WA) Pty Ltd ............................................................................................................................................. 8Australian Cancer Technology Ltd ........................................................................................................................ 10Clinical Cell Culture (C3) Pty Ltd .......................................................................................................................... 14Colltech Australia Pty Ltd ...................................................................................................................................... 15EqiTX ..................................................................................................................................................................... 19Genesis Biomedical Ltd ........................................................................................................................................ 21Lawley Pharmaceuticals Pty Ltd ........................................................................................................................... 23Orion Laboratories Pty Ltd .................................................................................................................................... 25Perth Bone and Tissue Bank Inc. ......................................................................................................................... 27Pharmacia Australia Pty Ltd .................................................................................................................................. 27pSivida Ltd ............................................................................................................................................................. 28Solbec Pharmaceuticals Ltd ................................................................................................................................. 29University of Western Australia, Office of Industry and Innovation ...................................................................... 31Uropath Pty Ltd & Tissugen Pty Ltd ...................................................................................................................... 32VRI Biomedical Limited ......................................................................................................................................... 33

VeterinaryAnimal Resources Centre ....................................................................................................................................... 8Chemeq Ltd ........................................................................................................................................................... 14Orion Laboratories Pty Ltd .................................................................................................................................... 25

Biotechnology Companies Not Elsewhere ClassifiedBiotechna_Graesser A.P. Castella Pty Ltd ........................................................................................................... 12Cognis Nutrition and Health .................................................................................................................................. 15Concept Fertility Centre ........................................................................................................................................ 15CSIRO Petroleum .................................................................................................................................................. 17CustomVis (CLVR Pty Ltd) .................................................................................................................................... 18Department of Conservation and Land Management .......................................................................................... 18Environmental Technology Centre ........................................................................................................................ 19Lions Cancer Institute (Inc) ................................................................................................................................... 23MedicVision Limited .............................................................................................................................................. 24Murdoch University Plant Biotechnology Research Group .................................................................................. 25PerkinElmer Life Sciences Pty Ltd ........................................................................................................................ 26ProMicro Pty Ltd .................................................................................................................................................... 27Raine Medical Research Foundation .................................................................................................................... 28Rowe Scientific Pty Ltd .......................................................................................................................................... 28Royal Perth Hospital .............................................................................................................................................. 28Rumen Biotech ...................................................................................................................................................... 29University of Western Australia, Department of Anatomy and Human Biology ................................................... 31Urological Research Centre .................................................................................................................................. 32Verigen Australia Pty Ltd ....................................................................................................................................... 32

Professional Service ProvidersAmmtec Ltd ............................................................................................................................................................ 36AtSource Organics Australia Pty Ltd .................................................................................................................... 36Biomedical Investments Ltd .................................................................................................................................. 36Biotechnology International Advisory Services .................................................................................................... 37

4

Centre for Medical and Surgical Skills (CTEC) .................................................................................................... 37Churchill Capital Services Pty Ltd ......................................................................................................................... 37Clayton Utz ............................................................................................................................................................ 37Corrs Chambers Westgarth .................................................................................................................................. 38Doug McGhie and Associates ............................................................................................................................... 38Ernst & Young ........................................................................................................................................................ 39Foundation Capital Ltd .......................................................................................................................................... 39Griffith Hack ........................................................................................................................................................... 39Innovation Research Australia .............................................................................................................................. 40Lakefield Oretest Pty Ltd ....................................................................................................................................... 41Lord and Company ................................................................................................................................................ 41Marketing Edge Agricultural Services ................................................................................................................... 42Mosaic Reputation Management .......................................................................................................................... 42The Oil Mallee Company of Australia Ltd ............................................................................................................. 42Pricewaterhouse Coopers ..................................................................................................................................... 43Symbion Ltd ........................................................................................................................................................... 43TechStart Australia Pty Ltd .................................................................................................................................... 43Tessitura Pty Ltd .................................................................................................................................................... 44Venture Capital Corporation International Pty Ltd ................................................................................................ 44Wray & Associates ................................................................................................................................................ 44

Industry Associations and Interest GroupsAusBiotech - Western Australia (WA) Branch ...................................................................................................... 45Australasian Association of Clinical Biochemists ................................................................................................. 45Australian Network for Plant Conservation ........................................................................................................... 45BioMed Alliance WA .............................................................................................................................................. 45

5

various stages of commercialisation and areattracting investment from around the world.Western Australia has eight biomedicalcompanies listed on the Australian StockExchange with a market capitalisation of morethan A$500 million.

Importantly, Western Australia is also home tobiomedical companies that are earning revenue.

Development of diagnostics, nanotechnology,medical devices and screening technologies alsofeature strongly in Western Australia.

� Agricultural BiotechnologyWestern Australia’s agricultural sectorcontributes more than A$4.5billion in exports tothe State’s economy. The strength of this sectorhas led to an emergence of companies in theagricultural-based biotechnology area, withcapabilities extending to agri-food, biologicaltesting, algal biotechnology, environmentalbiotechnology, therapeutics and drug discovery.

Agricultural biotechnology work in WesternAustralia is supported by the research conductedby the Department of Agriculture, the Universityof Western Australia (UWA), Curtin and MurdochUniversities, and in particular, the StateAgriculture Biotechnology Centre, which focuseson molecular biology, genomics and proteomicsfor research on plants, animals and micro-organisms.

Key developments include:• production of algae for carotenoid (beta-carotene)

production;• leading technology in the area of mass

spectroscopy (MALDI-TOF) which can be used toidentify cereal varieties;

• molecular plant breeding focusing on wheat andbarley;

• gene discovery, genetic enhancement andadvanced breeding technologies; and

• controlling disease in animal health throughdisease diagnosis and vaccine development.

Western Australia is also a world leader in wheatgenome research.

� Environmental BiotechnologyEnvironmental biotechnology research anddevelopment concentrates on potable watertreatment biotechnology, bioremediation, andbiological treatment of industrial waste.

Western Australia has a diverse and innovativerange of capabilities including:

• water, wastewater and sludge treatments usingbiological processes, as well as leading researchand development into the treatment of saline

Australia is recognised as being the No, 1for Biotechnology in the Asia Pacific region.

Perth, Western Australia is home to manycompanies, organisations and scientists that are atthe leading edge of research, development andcommercialisation.

Perth, Western Australia offers:

� Highly Skilled workforceWith five universities and technical educationinstitutions with specialist courses producing abroad range of biotechnology graduates.

� InnovationWestern Australia is well known in Australia forits innovative companies and is home to the mostsuccessful technology park in the country. TheState’s relative isolation has bred a culture ofinnovation and ingenuity to meet our needs.Academic, industry and government sectorsprovide a rich source of innovation which needpartners to assist in the commercialisation ofsome projects.

� Low Research CostsComparative studies have shown that whileWestern Australia enjoys a quality of life enviedby many (Perth was rank No. 3 in the world asthe best place to live in a recent internationalstudy) the overall costs of doing world-classresearch are a fraction of that in Europe and theUSA.

� BiodiversityWith over 2.5 million square kilometres (1 millionsquare miles) and 13,500 kilometres of coastline,Western Australia harbours one of the world’slargest collections of unique biota from climatesranging from sub-tropical through to temperateand Mediterranean and one of the largest reefsystems in the world.

Key Competencies:

In Western Australia, competence has beendeveloped over the past decade in five fields:

� BiomedicalWorld-class research is being undertaken acrossthe biomedical sector that is attracting significantlevels of investment by pharmaceutical and othercompanies in the biotechnology arena. WesternAustralia is home to a broad range of leading-edge research into the molecular basis of diseasecontrol, targeting diseases such as Alzheimer’s,cancer, diabetes, malaria and other parasiticdiseases. Many of the research programs are at

BIOTECHNOLOGY IS BOOMING . . . IN WESTERN AUSTRALIA

6

ecosystems and hyper-saline waste-watereffluent,

• remediation of contaminated land andgroundwater,

• renewable energy biomass systems, and• organic waste conversion using biodigestion.

� Bio-leaching and hydrometallurgicalprocessingAs a global centre for the resource sector,Western Australia has developed world-classexpertise in mining biotechnology such asbioleaching and hydrometallurgical processing.

The Western Australian-based, AJ ParkerCooperative Research Centre forHydrometallurgy, has grown to becomeAustralia’s largest hydrometallurgical researchorganisation, and is a major asset for Australia’sminerals industry. With a focus on improvingmineral processing biotechnology, its reasearchis saving the industry millions of dollars eachyear.

Research and development has also originatedfrom mining companies, expanding intobiotechnology to improve processing efficiencies.Expertise includes extractive ore processing,bacterial leaching solutions as well as world-class metallurgical and mineral testing.

� BioinformaticsWestern Australia’s Centre for Bioinformaticsand Biological Computing (CBBC) is at thecutting edge of bioinformatics.

The CBBC is working towards establishing acoordinated computational comparative analysisframework for Western Australia. The CBBC isdeveloping novel bioinformatics tools, databasesand integrated analysis systems for agriculturaland biomedical comparative genomic analysis.

Current research includes: (Re)annotation ofgenome sequences to identify candidate genes,creation and customisation of bioinformaticsanalysis pipelines, tracking, and quality projectmanagement of bioinformatics analyses, newalgorithms for bioinformatics analyses, molecularevolution, comparative genomic, functionalgenomics and proteomics analysis.

7

Advanced Nano Technologies Pty Ltd112 Radium StreetWelshpool 6106WESTERN AUSTRALIATel: +61 8 9380 8571Fax: +61 8 9380 1116Web: www.ant-powders.com

Senior Contact: Dr Hugh DawkinsPosition: Biomedical Product Development ManagerEmail: hugh@ant-powders.com

Company OverviewAdvanced Nano Technologies (ANT) is a joint venturebetween Advanced Powder Technologies of Australiaand Samsung Corning of Korea. ANT combines APT’sresearch strength and intellectual property withSamsung Corning’s industrial processing experienceand market power. The key goal of this venture is tocommercialise the Mechanochemical Processing.

Product/Services InformationAdvanced Nano Technologies (ANT) has developed anew low cost process for the manufacture of a widerange of ultra fine and nanoscale powders. Throughits patented MCPTM Technology ANT supplies highquality, non-agglomerated powders that can beindividually tailored to meet customer requirements.The ability to uniquely engineer particle size and shape,combined with the inherent low cost nature ofMechanochemical Processing Technology, sets ANTpowders apart in the nanomaterials market.Ag-Id Pty LtdPO Box 92Claremont 6010WESTERN AUSTRALIATel: +61 8 9383 3876Fax: +61 8 9384 8840

Senior Contact: Mr Josef PfistershammerPosition: Managing DirectorEmail: josefpf@iinet.net.au

Company OverviewThe company provides the INTEGRI-TAG™ SYSTEMfor the fail-safe analysis of livestock DNA. This uniquesystem comprises of a tagging gun, special tissuecollecting tips and a sorter/extractor. The tagging gunis a mechanical actuator assisted device that makesthe tagging task easy and very humane compared withexisting technologies. The tips are specially designednot only to capture the DNA-containing tissue, but alsoto preserve the sample indefinitely. This is in contrastto current tissue collecting devices that require thesample be analysed within two days of collection, whichgenerally is not a viable option for potential users giventhe lack of an appropriate infrastructure.

Product InformationTechnology: The INTEGRI-TAG™ SYSTEM is the firststep in a more efficient and effective DNA analysisprocesses. The system facilitates in a seamlessfashion the fail-safe: 1) traceback of future productsfrom the animal; 2) genetic profiling of the animal forbreeding and management purposes; and 3) theft-proofing by verifying the ownership by DNA

comparison. The INTEGRI-TAG™ SYSTEM will enablethe effective tracing of meat products throughout theentire food chain. The system assists with establishinganimal identification through the collection of abiological sample of a particular animal for subsequentDNA analysis. This tissue sample collected at birth istaken and preserved in 2-D matrix coded capsulesusing the INTEGRI-TAG™ SYSTEM. The capsules aresorted and deposited in 96 wellplate frames by thecompany’s proprietary Extractor. The 2-D codes areread with a cheap digital camera and the position ofthe sample with its corresponding eartag number isthen stored in the database. The tissue is then eitherdissolved with a weak NaOH solution or the entiretissue sample is extracted for further processing.

Agri-BIOTECH Pty LtdPO Box 570Claremont 6910WESTERN AUSTRALIATel: +61 8 9285 5525Fax: +61 8 9384 4811Web: www.agri-biotechnology.com

Senior Contact: Dr Guan TayPosition: Research DirectorEmail: gtay@agri-biotechnology.com

Company OverviewAgri-BIOTECH Pty Ltd is a company incorporated inWestern Australia. When it was initially established,our mission was to develop biotechnologies to servicethe specific requirements of users in Western Australia(WA). Since then, the services have been extendedto users throughout Australia and we are currentlypursuing opportunities off-shore.DNA testing commenced in 2001 at laboratories basedin Perth. Since this time, we have collected samplesfrom cattle, sheep, pigs, goats and horses for DNAtesting. Our R&D program has also grown and nowincludes the development of DNA-based systems todifferentiate between individuals and the assessmentof genetic merit of breeding stock.In the delivery of services to date, Agri-BIOTECHrecognises the need to provide pragmatic solutions tomake DNA-information more relevant to daily androutine applications. To facilitate this, we areexpanding our growth opportunities by establishing aR&D and production facility in rural WA to complementour current efforts in the metropolitan area.Agri-BIOTECH has specifically chosen to expand itsR&D facilities in rural WA as it is deemed essentialtowards the creation of new industries and jobs basedwithin the agricultural sector.

Product InformationAgri-BIOTECH laboratories were established toprovide customised DNA testing for livestock usingtechnologies that include STR or microsatelliteanalyses, SNP detection and DNA-based sequencing.Agri-BIOTECH is also directly involved in productionof livestock. It uses DNA technology to enhance thegenetic merit of its Boer goat stock on its studproduction facility, Rockdale Farm.

8

Alzhyme (WA) Pty LtdLevel 21, 197 St Georges Terrace220 St Georges TerracePerth 6000WESTERN AUSTRALIATel: +61 8 9480 1184Fax: +61 8 9480 1199Web: www.alzhyme.com

Senior Contact: Mr Marcus ChristianPosition: Chief Executive OfficerEmail: marcus.christian@techstart.com.au

Company OverviewAlzhyme is a start-up company dedicated to thesuccessful development of therapeutic agents capableof arresting the progression of Alzheimer’s disease(“AD”). Alzhyme’s initial approach derives from theresearch developed by Professor Ralph Martins, aninternationally renowned as a leader in the field ofAlzheimer’s disease research. Alzhyme has recruiteda Scientific Advisory Group consisting of world leadersin the area of Alzheimer ’s research and drugdevelopment. The company was incorporated followingits success in obtaining a coveted BiotechnologyInnovation Fund grant, which was matched by privateinvestment.

Product InformationAlzhyme’s current R&D Plan involves the identificationand validation of compounds with high specificity-binding to the region within the neuropeptide BetaAmyloid (“Aß”) which has been identified as being criticalto its toxicity and aggregation. It is now widely acceptedthat it is the action of Aß that leads to the destruction ofneurons and deterioration of mental function.Alzhyme utilises the unique knowledge, skills andabilities of the University of Western Australia’s SirJames McCusker Alzheimer’s Disease Research Unitat Hollywood Private Hospital. Under the guidance ofResearch Director, Associate Professor Ralph Martins,this group has developed novel drug targets forAlzheimer’s disease. Based on these discoveries,proprietary techniques and capabilities have beendeveloped for identification and pre-clinical testing ofpharmaceutical candidates. Alzhyme aims to validateits candidates in readiness for further developmentthrough to clinical trials.

Animal Resources CentrePO Box 1180Canning Vale 6155WESTERN AUSTRALIATel: +61 8 9332 5033Fax: +61 8 9310 2839Web: www.arcwa.wa.gov.au

Senior Contact: Dr David PassPosition: DirectorEmail: dpass@arcwa.wa.gov.au

Company OverviewThe Animal Resources Centre specialises in theproduction and importation of Specific Pathogen Freemice and rats for supply to the biomedical andbiotechnological research and development community

within Australia, New Zealand, Singapore and HongKong. In association with Ozgene Pty Ltd we createand produce new strains of genetically modified(transgenic and knockout) mice according toresearchers’ requirements. We specialise in custombreeding and maintaining of strains for individualcustomers.

Product Information• Specific pathogen free laboratory mice and rats• Knockout mice• Transgenic mice• Transgenic rats

Aquabiotics Pty Ltd14 Goongarrie StreetBayswater 6053WESTERN AUSTRALIATel: +61 8 9379 2911Fax: +61 8 9379 2811Web: http://ironbacteria.com/PROFILE.HTM

Senior Contact: Mr David BennettPosition: Managing DirectorEmail: daveb@space.net.au

Company OverviewAquabiotics offers a comprehensive suite of solutionsto iron problems in groundwater. The company is nowa world leader, offering the best technology at asignificantly lower price of other, less effectiveapproaches.

AquaCarotene LimitedPO Box 335West Perth 6872WESTERN AUSTRALIATel: +61 8 9382 1222Fax: +61 8 9388 2748Web: www.aquacarotene.com

Senior Contact: Mr Donald SmithPosition: Executive DirectorEmail: admin@aquacarotene.com

Company OverviewAquaCarotene Limited is involved with the growth,harvesting and recovery of natural betaCarotene andassociated value-adding operations. The entireproduction process and delivery of the productconcentrate is from a unique Western Australianlocation, and entirely by natural means.

Product InformationBetaCarotene is a naturally occurring substancecommonly found in red, orange, and green fruit andvegetables. BetaCarotene is one of the most potentCarotenoids available, aiding in the transfer of lightenergy to chemical energy, while providing pigmentcolouring. AquaCarotene derives its source of NaturalbetaCarotene from the culture Dunaliella Salina.There are four main uses for the Natural betaCarotenematerial:• a food colourant source,• a nutritional dietary supplement for fish, shrimp and

prawn farms,

9

• for the cosmetic industry as a natural colour source,and

• the vitamin industry in encapsulated from products,eg. multivitamins, anti-oxidants etc.

Argus Biomedical Pty LtdLions Eye Institute Building, 2 Verdun StreetNedlands 6009WESTERN AUSTRALIATel: +61 8 9381 0761Fax: +61 8 9381 0759Web: www.argusbiomedical.com

Senior Contact: Mr David CoxPosition: Accreditation & Marketing ManagerEmail: davidcox@argusbiomedical.com

Company OverviewArgus Biomedical Pty Ltd is a private company with itsorigins in the Biomaterial and Polymer Research groupof the Lions Eye Institute in Western Australia Inc (LEI).Argus Biomedical has acquired the exclusive rights fromLEI to commercialise -AlphaCor™ the world first soft,one-piece artificial cornea and AlphaSphere™ a softbiointegrable orbital implant. Argus Biomedical iscommitted to being the leader in the manufacture andsupply of Artificial Corneas and Orbital Implants,enabling surgeons worldwide to restore patients to theirbest visual acuity and/or maximise their quality of life.

Product InformationAlphaCor™ is a biocompatible, flexible, one-pieceartificial cornea (keratoprosthesis) designed to replacea scarred or diseased native cornea. AlphaSphere™Orbital implants are required when a person loses aneye due to disease or trauma. The orbital implantoccupies the space usually filled by the eyeball andgives substantial cosmetic benefits to the patient.

Artemia Biotechnology Centre Pty Ltd5 Fifth AvenueRossmoyne 6148WESTERN AUSTRALIATel: +61 8 9457 1074Fax: +61 8 9457 3785

Senior Contact: Ms Edith PadillaPosition: Managing DirectorEmail: abcmultimedia@ieee.orgCompany OverviewThe Artemia Biotechnology Centre (ABC) started as acompany in Gent, Belgium in 1983. A branch-office wasset-up in Perth, Western Australia in 1988, initially as afree-lance consultancy servicing the local Solar Saltindustry. This became a permanent base in 1989,servicing the SE-Asian region’s salt producers and thenewly established aquaculture industries. We have over15 years international expertise in environmentalengineering, mainly in the treatment of saline effluents.We performed ecological studies and biologicalmanagement for the major commercial solar salt fieldoperators in Australia and were involved with innovativewastewater treatment research, using biologicalindicators for nutrient stripping and advanced tertiarytreatment.

Product InformationAquaculture Engineering, Environmental & RiskEngineering, Marine Ecology, Food Technology, Nutrientrecovery from waste-water, Hyper-saline effluenttreatment, Solar salt field biological management.

Asthma & Allergy Research Institute IncE Block, Sir Charles Gairdner HospitalVerdun StreetNedlands 6009WESTERN AUSTRALIATel: +61 8 9346 3198Fax: +61 8 9346 4159Web: www.aari.uwa.edu.au

Senior Contact: Prof Phillip ThompsonPosition: DirectorEmail: aari@aari.uwa.edu.au

Company OverviewThe Asthma and Allergy Research Institute (AARI) isthe only integrated scientific and clinical researchinstitute in Australia dedicated specifically to researchinto respiratory and allergic disease. AARI is locatedat Sir Charles Gairdner Hospital in Perth, is formallyaffiliated with the University of Western Australia and isan accredited National Health & Medical ResearchCouncil Institute. Our primary goals are to support highquality research into the treatment and managementof patients with asthma, allergic diseases and other lungdiseases including chronic bronchitis, emphysaema andpulmonary fibrosis, to improve the well-being of patientsand to support the careers of young scientists.

Australian BiosearchUnit 3, 152 Balcatta RoadBalcatta 6021WESTERN AUSTRALIATel: +61 8 9344 1200Fax: +61 8 9345 1259Web: www.aust-biosearch.com.au

Senior Contact: Mr GraemePosition: Managing DirectorEmail: graeme@aust-biosearch.com.au

Company OverviewAustralian Biosearch specialise in the support ofAustralia’s Life scientists with products, service andsupport from leading Life Science manufacturers.Australian Biosearch is a distributor of BiosourceProducts. Biosource International, Inc. is a broad basedlife sciences company focused on providing solutionsin the areas of functional proteomics and advanced drugdiscovery through the development, manufacturing,marketing, and distribution of unique biologically activereagent systems which facilitate, enable, and acceleratepharmaceutical development as well as biomedicalresearch. While much of the work here at BioSourcetakes place behind the scenes of the biotechnology andhealth sciences industries, they are proud of ourcontributions to the advancement of scientificknowledge.

10

Australian Cancer Technology LtdGround Floor1 Havelock StreetWest Perth 6005WESTERN AUSTRALIATel: +61 8 9486 4622Fax: +61 8 9486 4933Web: www.austcancer.com.au

Senior Contact: Mr Alistair CowdenPosition: Managing DirectorEmail: reception@austcancer.com.au

Company OverviewAustCancer is an ASX listed company that has aportfolio of oncology technologies targeting largeunmet cancer markets. The company provides acommercial focus, technical expertise andrelationships with prominent clinical research facilitiesto advance the most promising candidate treatmentsthrough clinical trials. AustCancer has three cancertreatment technologies in development, including thePentrix™ vaccine, which has completed Phase 1b/2aclinical trials and has the potential to treat up to 50%of all cancers. The other two projects are carried outin a joint venture with UK listed company BioFocus .AustCancer has:• a management team and board with extensive

experience in the management of publiccompanies, biotechnology companies and inscientific research both in Australia andinternationally;

• worldwide exclusive licence to commercialise thePentrix™ vaccine (described below);

• strategic alliance with BioFocus , a leading UKbased drug discovery and chemistry serviceprovider listed on AIM, which gives AustCancerongoing access to a product pipeline of potentialtreatments; and

• a flexible listed structure with the capacity toaccommodate a number of commercial structuresto suit potential partners.

Product InformationPentrix™ Vaccine - Has the potential to treat up to 50%of all cancers unlike most cancer therapies which aretargeted at very specific cancer types. Does not involvethe use of cells as is common with current cancervaccines. This gives Pentrix™ advantages overcompeting technologies due to reduced cost ofproduction, reduced time taken for treatment and lesscomplex regulatory issues. Many cancer vaccineshave to be individually tailored to the patient. ThePentrix™ vaccine is universal, the same vaccine beingadministered to all patients.Pentrix™ cancer vaccine is - a broad-spectrum cancervaccine which targets mutations in the p53 tumoursuppressor gene; a mutations in the p53 gene arepresent in up to 50% of all cancers; the Pentrix™cancer vaccine is an anti-idiotypic vaccine, whichovercomes the issue of self-tolerance, which is a majorbarrier for most cancer vaccines; patent, which coversa panel of synthetic human antibodies produced bythe p53 tumour suppressor gene.

These are the only human p53 antibodies currentlyavailable in the world; phase 1 clinical trial has beensuccessfully completed and phase 2 is due tocommence in the second half of 2003.Breast cancer therapeutics - Using extensive chemicallibraries, state of the art high throughput screeningand retroviral display technology discovered a familyof small molecules that target the same receptor familyas Genetech’s breast cancer treatment, Herceptin($1bUS market); 50:50 joint Venture with BioFocusplc; advantages of a small molecule include, lowercost of production and greater stability/effectiveness;potential treatment for hormone unresponsive breastcancer. ChK1 Kinase - focused on discovering smallmolecule inhibitors of ChK1 kinase which is involvedin cell cycle arrest in response to DNA damage; suchan inhibitor is likely to increase the effectiveness ofradiotherapy and some chemotherapies, reducingdosage and therefore toxicity; and 50:50 Joint Venturewith BioFocus plc.

Australian Institute of Marine Science (AIMS)PO Box 83Fremantle 6959WESTERN AUSTRALIATel: +61 8 9433 4440Fax: +61 8 9433 4443Web: www.aims.gov.au

Senior Contact: Dr Russell ReicheltPosition: DirectorEmail: reception@aims.gov.au

Company OverviewThe Australian Institute of Marine Science (AIMS) wasestablished by the Commonwealth government in1972 to generate and transfer the knowledge neededfor the sustainable use and protection of the marineenvironment through innovative, world-class scientificand technological research.

Australian Neuromuscular Research InstituteLevel 4, A BlockQEII Medical Centre, Verdun StreetNedlands 6009WESTERN AUSTRALIATel: +61 8 9346 2818Fax: +61 8 9346 3487Web: www.anri.uwa.edu.au

Senior Contact: Prof. Byron KakulasPosition: Medical DirectorEmail: bkakulas@cyllene.uwa.edu.au

Company OverviewThe objective of the Australian NeuromuscularResearch Institute is to significantly improve the healthand welfare of the Australian community by searchingfor and pioneering the introduction of methods ofprevention and treatment of neuromuscular disorders.In particular conditions in which it has special expertisethe Institute seeks to provide a focal point for theintegration of all possible basic and clinical researchapproaches with ongoing health care in a sympatheticand supportive environment.

11

Australian Research Centre for MedicalEngineeringMurdoch UniversitySouth StreetMurdoch 6150WESTERN AUSTRALIATel: +61 8 9360 2925Web: www.arcme.com

Senior Contact: Prof. Yianni AttikouzelPosition: Executive DeanEmail: yianni@arcme.com

Company OverviewThe ARCME has established a nexus between medicalresearch and engineering, with a unique commercialemphasis that will make Australia a focal point in theregion, and one of the leaders of a discipline rareanywhere in the world.

Bactech (Australia) Pty Ltd168 Stirling HighwayNedlands 6009WESTERN AUSTRALIATel: +61 8 9423 5900Fax: +61 8 9389 1750Web: www.bactech.com

Senior Contact: Mr Geoff DonohuePosition: DirectorEmail: info@bactech.com

Company OverviewBacTech is a publicly listed Canadian company with itsshares quoted on the Canadian Venture Exchange(CDNX). The company has operated since 1988 withits origin in Western Australia and was incorporated inmid 1997 in Ontario, Canada and went public inSeptember of the same year. The company ownsproprietary bacterial oxidation technology that liberatesprecious and base metals from difficult to treat sulphidesores and concentrates. It has the advantages ofimproving metal recovery at significantly lower capitaland operating when compared to the traditionaltreatment methods of smelting, roasting and pressureoxidation. BacTech is a proven leader in thecommercialisation of bacterial oxidation technology inthe metal extractive industry. Bacterial oxidation is thesafe, environmentally friendly use of naturally occurringbacteria to aid in the extraction of precious and basemetals from sulphide ores and concentrates.

Product InformationBacTech owns innovative technology for use in theextraction of precious and base metals from difficult toprocess refractory sulphide ores and concentrates. Ourtechnology uses bacteria to break down the mineralmatrix by oxidation and release the metals for recoveryby conventional means. A wide range of precious andbase metal ores have proven amenable to suchtechnology. Gold can be freed by oxidation from themineral matrix in which it is held, and once in residuecan be recovered by cyanidation. Base metals such ascopper pass into solution and can be recovered using

solvent extraction and electrowinning. The process iscarried out at ambient temperature and pressure whichreduces capital and operating costs compared toalternative processes carried out on a similar scale.

BioEnergy Australia Pty LtdGPO Box 2526Perth 6001WESTERN AUSTRALIATel: +61 8 9225 7888Fax: +61 8 9225 7999Web: www.bioenergyaustralia.com.au

Senior Contact: Cliff PeifferPosition: Managing DirectorEmail: cliff@bioenergyaustralia.com.au

Company OverviewBioEnergy has developed a forestry/renewable energycompany that is unique globally. In developing asystem whereby a quality wood fibre resource can bedelivered to the market within 3 to 5 years of plantingand a quality sawn wood product can be deliveredwithin 10 years, BioEnergy can reach markets in atimeframe which is ordinarily measured in decades.The Company has funded privately an extensiveresearch and development program resulting insignificant intellectual property in bioenergy frombiomass systems and in mixed species plantations.

Product InformationTo capitalise on this extensive body of R&D andcommercialise its substantial intellectual property,BioEnergy has decided to launch a Wholesale ForestryManaged Investment Scheme through its wholly ownedsubsidiary BioForest Limited.

Bio-Gene Technology Pty LtdUnit 25, 123 Collin StreetWest Perth 6005WESTERN AUSTRALIATel: +61 8 9321 7477Fax: +61 8 9322 1118Web: www.bio-gene.com.au

Senior Contact: Mr Kevin RumblePosition: DirectorEmail: kr@bio-gene.com.auCompany OverviewBio-Gene Technology is a 100% Western Australiancompany owned by twenty-eight Western Australianshareholders, each of whom are separate successfulbusiness proprietors in the state. Bio-Gene Technologywas formed in 1996 with its purpose to identify, culture,farm, harvest and extract marketable products fromindigenous Australian Flora and Fauna.

Product InformationBio-gene grows and harvest’s Boronia megastigma (aplant only found in the South west of Western Australia)for it’s essential oil. Boronia oil is a rare an exotic oilthat is used to enhance the top notes of flavour andfragrance.In addition Bio-gene makes products using Australianessential oils. These products have no peer and are

12

naturally occurring biodegradable and none toxic. Aswe discover more compounds from Australian nativeswe will increase our product range, allowing us to sellconcentrated essential oils or developed products forthe world market.We are interested in any body wishing to introduce newnatural occurring products that are non toxic to theirmarket to make contact with us.We also provide independent plant chemical analysisand manage grow out programs for some of theAustralian natives where compounds are requirednaturally.

Biomax Pty Ltd7 Kingscote StreetKewdale 6105WESTERN AUSTRALIATel: +61 8 9353 6886Fax: +61 8 9353 6883Web: www.biomax.com.au

Senior Contact: Mr Suresh UnniEmail: info@biomax.com.au

Company OverviewBioMAX undertakes design, manufacture, installationand commissioning as well as maintenance ofBioMAXTM Aerobic Treatment Systems for wastewatertreatment and recycling applications ranging from singlehouseholds to large commercial establishments. Ourconsultancy branch carries out specific research anddevelopment projects in the fields of environmentalengineering and management.

BioProspect Ltd4 Parker PlaceTechnology ParkBentley 6102WESTERN AUSTRALIATel: +61 8 9262 0106Fax: +61 8 9474 3953Web: www.bioprospect.com

Senior Contact: Mr Matt KealleyPosition: Chief Field ScientistEmail: matt.kealley@bioprospect.com

Company OverviewBioProspect is a natural product discovery companywit its core focus in the discovery, research anddevelopment of commercial products from a broadrange cross-section of biological resources collectedin Australia.

Product InformationBioProspect has an established natural extract librarysourced from biota of Western Australia andQueensland. This library is continually being increasedthrough new collections.BioProspect’s products include Qcide, a naturalinsecticide that is currently being evaluated by severalagrochemical companies. BioProspect is alsofocussing on several discoveries ranging from termiteand pest control through to prostate and breast cancer.BioProspect has formed partnerships with worldrenowned plant biologists and chemists, allowing the

company to provide a state of the art service that canbe customised to meet the needs of a variety ofindustries including the pharmaceutical, nutraceuticaland agrochemical industries.

Biorex Health LtdPO Box 3021Malaga 6945WESTERN AUSTRALIATel: +61 8 9249 1450Fax: +61 8 9249 1424

Senior Contact: Mr Jerry BurongPosition: DirectorEmail: JerryBurong@biorexhealth.com

Company OverviewAgritechnologies

Biotechna_Graesser A.P. Castella Pty LtdLot 6 Weston RoadPickering Brook 6076WESTERN AUSTRALIATel: +61 8 9293 8273Fax: +61 8 9293 8293

Senior Contact: A/Prof Michael BorowitzkaPosition: Managing DirectorEmail: borowitzka@bigpond.com.au

Company OverviewParent organisation is Biotechna EnvironmentalTechnologies

Botanic Gardens and Parks Authority (KingsPark)Fraser AvenueWest Perth 6005WESTERN AUSTRALIATel: +61 8 94803600Fax: +61 8 93225064Web: www.bgpa.wa.gov.au

Senior Contact: Dr Stepehn HooperPosition: Chief Executive OfficerEmail: enquiries@bgpa.wa.gov.au

Company OverviewThe Botanic Gardens & Parks Authority aims to:• create and provide world recognised facilities and

services and to inspire the conservation ofbiodiversity, and

• conserve and enhance Kings Park, Bold Park andthe State’s Botanic Garden for the community.

Canola Breeders Western Australia Pty LtdFaculty of AgricultureUniversity of Western Australia35 Sitrling HighwayNedlands 6009WESTERN AUSTRALIATel: +61 8 9380 2563Fax: +61 8 9380 1098Web: www.cbwa.net.au

13

Senior Contact: Bob LindnerPosition: DirectorEmail: blindner@agric.uwa.edu.au

Company OverviewCanola Breeders Western Australia Pty Ltd, establishedin June 2001, is the only commercial canola breedingcompany based in Western Australia. It represents aunique partnership between growers and researchersin WA, linked to international plant breeding andcommercial expertise. The company’s vision is for aprosperous, independent and sustainable WesternAustralian canola industry based on specificallyadapted varieties.

Centre for Bioinformatics and BiologicalComputingMurdoch UniversitySouth StreetMurdoch 6150WESTERN AUSTRALIATel: +61 8 9360 6088Fax: +61 8 9360 7238Web: www.cbbc.mourdoch.edu.au

Senior Contact: Associate Professor Matthew BellgardPosition: DirectorEmail: m.bellgard@murdoch.edu.au

Company OverviewThe mission of the Centre for Bioinformatics andBiological Computing (CBBC) at Murdoch University isto use information technology to foster understandingof biological systems, evolution and improve the qualityof life. To achieve this, the CBBC is striving to establisha track record in Bioinformatics research anddevelopment, service delivery and education. To date,the CBBC working towards building a critical mass ofBioinformatics expertise and resources, and hasdemonstrated an ability to solve a range of challengingbioinformatics problems.Current research includes the following three aspects:Information Systems (tracking and quality managementof bioinformatics analyses), computation (newalgorithms for bioinformatics analyses) and molecularevolution and comparative genomic analyses. Currently,there are nine staff for research and teaching.

Product InformationThe CBBC offers a range of services:1) Genomic public repository mirrors for database

searching: mirror relevant genomic datasets locallyin WA for biomedical researchers; create robust andreliable database searching capability for thesedatasets linking information from other internationalsites; customise datasets for specific scientific needs(eg. formatting datasets, integrating disparateinformation from various external sources,customising searching parameters); and access viathe internet.

2) New Bioinformatics tools: host specific existingbioinformatics software programs for - convenienceto end users (minimise network and internetbottlenecks), customisation of tools to specific needs

of individual researchers, creating user-friendlydatabase and software interfaces; and develop newbioinformatics algorithms for various bioinformaticsdata analysis.

3) EST and contig assembly: customise internationalEST databases for searching by local researchers;and develop user-friendly interfaces to assist in SNPidentification

4) Comparative analysis and Genome sequenceannotation (looking for new genes): develop web-based tool to (re)annotate genome sequences byindividual researchers; and conduct research incomparative genomic analysis and molecularevolution .

5) DNA fingerprints and Proteomic data analysis:develop new algorithms for DNA and protein profiling(classification)

6) Microarray data analysis: conduct microarray dataanalysis; user support (bioinformatics softwareprograms); and database establishment.

Centre for High-throughput Agricultural GeneticAnalysis (CHAGA)Murdoch UniversitySouth StreetMurdoch 6150WESTERN AUSTRALIATel: +61 8 9360 2122Fax: +61 8 9360 6303Web: http://wwwscieng.murdoch.edu.au/centres/chaga/

Senior Contact: Prof Keith GreggPosition: DirectorEmail: kgregg@central.murdoch.edu.au

Company OverviewCHAGA is dedicated to the research and developmentof methods for genetic analysis and, throughautomation and simplification, to make high-throughputgenetic analysis available and affordable to theAgricultural Industries.CHAGA is a joint venture of Murdoch University, CurtinUniversity of Technology, Department of Agriculture WA,and Saturn Biotech Ltd, established with WA StateGovernment Centre of Excellence funding.

Centre for Human Genetics100 Joondalup DriveJoondalupWESTERN AUSTRALIATel: +61 8 9400 5716Fax: +61 8 9400 5851Web: http://www.chg.ecu.edu.au/centre.html

Senior Contact: Prof Alan BittlesEmail: a.bittles@ecu.edu.au

Company OverviewThe studies conducted by the Centre for HumanGenetics have provided critical information on basichuman genome structure and function and, at the sametime, assisted national and international health bodiesin the assessment of specific aspects of the overall

14

burden associated with genetic disease. The work ofthe Centre also has permitted the development andimplementation of cost-effective, preventive healthstrategies for serious inherited diseases, includingcommunity-specific carrier screening, predictive testing,and pre-marital counselling.

Centre for Microscopy and MicroanalysisUniversity of Western Australia35 Stirling HighwayNedlands 6009WESTERN AUSTRALIATel: +61 8 9380 2770Web: http://cmm.uwa.edu.au/

Senior Contact: Associate Professor Brendan GriffinPosition: DirectorEmail: admin@cmm.uwa.edu.au

Company OverviewThe Centre for Microscopy and Microanalysis providesessential teaching and research infrastructure inelectron microscopy, l ight microscopy andmicroanalysis to the Universities, the Government ofWestern Australia and local industry.

Centre for Molecular Immunology &InstrumentationPO Box 5100Canning Vale 6155WESTERN AUSTRALIATel: +61 8 9397 1556Fax: +61 8 9397 1559Web: http://www.research.uwa.edu.au/centres/welcome/centres/centre_for_molecular_immunology_and_instrumentation

Senior Contact: Prof Roger DawkinsPosition: DirectorEmail: cmii@cyllene.uwa.edu.au

Company OverviewAims of the Centre include: 1) To understand humanevolution in the context of disease and polymorphismwith particular attention to the role of retroviruses; 2)To identify new genes via genomic prospecting; 3) Toimprove the outcome of Transplantation; and 4) Todevelop equipment and software to facilitate these aims

Chemeq Ltd3 Brodie Hall DriveBentley 6102WESTERN AUSTRALIATel: +61 8 9362 0100Fax: +61 8 9355 0199Web: www.chemeq.com.au

Senior Contact: Dr Graham MelrosePosition: Chairman & Chief Executive OfficerEmail: graham.melrose@chemeq.com.au

Company OverviewChemeq Ltd is a leading Australian pharmaceuticalcompany that began as a research-intensive private

company in 1989. Chemeq Ltd is developing,manufacturing and marketing antimicrobials,particularly CHEMEQ® polymeric antimicrobial (forpigs) and CHEMEQ® polymeric antimicrobial (forpoultry). (An antimicrobial is a substance that inhibitsthe growth or kills micro organisms/germs).

Product InformationCHEMEQ® Polymeric antimicrobial which is used inthe prevention and reduction of debilitating infectionsin the intestines of intensively-reared animals,particularly pigs.

Chemistry Centre (WA)125 Hay StreetEast Perth 6004WESTERN AUSTRALIATel: +61 8 9222 3177Fax: +61 8 9325 7767Web: www.ccwa.wa.gov.au

Senior Contact: Mr Neil RothniePosition: Chief Of LaboratoryEmail: nroth@ccwa.wa.gov.au

Company OverviewResearch and Development Service Provider

Clinical Cell Culture (C3) Pty LtdUnit 5, 6 Brodie Hall DriveBentley 6102WESTERN AUSTRALIATel: +61 8 9355 6288Fax: +61 8 9470 6388Web: www.clinicalcellculture.com

Senior Contact: Ms Helen WrayEmail: helenw@clinicalcellculture.com

Company OverviewClinical Cell Culture (C3) is a publicly listed biomedicalcompany, which develops and distributes tissue-engineered cellular products for autologous skinreplacement. C3 was founded in 1999 and was recentlyacquired by ECAT Development Capital and listed onthe ASX on November 14, 2002 (ASX: CCE). C3 strivesfor excellence in the development and delivery ofinnovative cell regeneration technologies. We arecommitted to providing the highest quality solutions forour customers to continually improve patient outcomesand exceed the expectations of our shareholders.

Product InformationOur proprietary skin replacement products, includingour lead product CellSpray® (cultured epithelialautograft spray suspension), offer physicians a rangeof options for the treatment of burns, other epidermaltrauma, previous scarring, chronic wounds and forcosmetic procedures. C3’s products have been usedto treat more than 1100 patients throughout Australiaand New Zealand and in select cases in the UK, SouthAfrica, Malaysia and Hong Kong. CellSpray®,CellSpray® Express and ReCell® were used to treatmany of the burn victims of the Bali bombing including

15

patients from Australia, New Zealand, Germany andIndonesia. C3 is committed to making a difference forall patients by commercialising its products worldwide.

Cognis Nutrition and HealthLot 6 Weston RoadPickering Brook 6076WESTERN AUSTRALIATel: +61 8 9293 8293Fax: +61 8 9293 8293Web: www.cognis.com

Senior Contact: Dr Leslie BorowitzkaPosition: Managing DirectorEmail: borowitzka@bigpond.com.au

Company OverviewIn Western Australia, Cognis Nutrition and Healthproduce micro algae for the production of Beta Caratoneproducts.

CollTech Australia Pty LtdUnit8, 232 Churchill AvenueSubiaco 6008WESTERN AUSTRALIATel: +61 8 9388 6075Fax: +61 8 9388 9202Web: www.colltech.com.au

Senior Contact: Dr David KennedyPosition: ChairmanEmail: dkennedy@colltech.com.au

Company OverviewCollTech - the extraction, purification, and distribution ofcollagen and collagen-enhanced products to themolecular medicine and biotechnology markets.

Concept Fertility Centre374 Bagot RoadSubiaco 6008WESTERN AUSTRALIATel: +61 8 9382 2388Fax: +61 8 9381 3603Web: www.conceptfert.com.au

Senior Contact: Rhys BellingeEmail: rhys@conceptfert.com.au

Company OverviewFounded in 1981, Concept Fertility Centre offers the mostcomprehensive range of fertility services available inWestern Australia.

Cottman SBASuite 3, 73 Troy TerraceSubiaco 6008WESTERN AUSTRALIATel: +61 8 9388 3866Fax: +61 8 9388 3838Web: www.cottmansba.com

Senior Contact: Mr Tim HoustonPosition: Chief Executive OfficerEmail: thouston@cottmansba.com.au

Company Overview

Formed in 1999, Cottman SBA was created by themerger of two long established and highly respecteddistribution companies, L.J. Cottman (WA) Pty Ltd andSurgical Buyers (Australia) Pty Ltd. Both thesecompanies are subsidiaries of Inovax Limited (symbolINX.AX), a public company listed on the AustralianStock Exchange. Cottman SBA draws on some 30 yearsexperience in providing solutions to the health careindustry.

Product InformationCottman SBA carry around 12,000 medical, surgicaland pharmaceutical products.

CRC for Legumes in Mediterranean Agriculture(CLIMA)University of Western Australia35 Stirling HighwayCrawley 6009WESTERN AUSTRALIATel: +61 8 9380 2505Fax: +61 8 9380 1140Web: www.clima.uwa.edu.au

Senior Contact: Prof. Kadambot SiddiquePosition: DirectorEmail: ksiddiqu@agric.uwa.edu.au

Company OverviewCLIMA is a research alliance which pools the talentand resources of the Department of Agriculture,Western Australia; The University of Western Australia;CSIRO and Murdoch University to study the role of grainand annual pasture legumes in sustainable agriculturein the Mediterranean climate of south western WesternAustralia.

Product InformationDevelopment of new varieties in pasture and grainlegume speciesCharacterisation and evaluation of genetic resourcesin grain and pasture legumesTransformation technology for grain and pasturelegumesDevelopment of tools to enable utilisation of wild grainlegume relatives for crop improvementDevelopment of tissue culture techniques to supportgrain legume breedingMolecular markers for legume crop improvement

CSIROPrivate Bag No. 5Wembley 6913WESTERN AUSTRALIATel: +61 8 9333 6603Fax: +61 8 9387 8991Web: www.csiro.au

Senior Contact: Mr Mick PoolePosition: HeadEmail: m.poole@ccmar.csiro.au

Company OverviewCSIRO (the Commonwealth Scientific and IndustrialResearch Organisation) is a statutory agency of theGovernment of Australia and one of the world’s largestand most diverse scientific research institutions,employing some 6,500 staff in more than 65 sites

16

around Australia and overseas. Researchcollaborations stretch across more than 70 countries.CSIRO conduct world-class research for many industrysectors spanning agriculture, communications,construction, pharmaceutical & human health,environmental and natural resources, manufacturing,information & services, and minerals & energy, and areactively pursuing commercialisation ventures andalliances to enhance the adoption of research. CSIROdiverse capabilities in biotechnology covers all fieldsof human health, agricultural, environmental andchemical biotechnologies, which allows us to build crossdisciplinary teams to deliver solutions in areas like:Bioinformatics, Functional Genomics, Proteomics andStructural Biology, Biodiscovery, Biomarkers,Biomaterials, Bioprospecting, Biopesticides,Bioprocessing, Bioremediation, Biotherapeutics,Molecular Engineering, Nanotechnology, andEcological impacts of transgenes.

Product InformationProtein engineering Mammalian cell; Culture/fermentation and protein purification; X-raycrystallography, structure determination; In silicoscreening, rational drug design; Gene markers for betterlivestock productivity; Genetics in aquaculturecapabilities; Enzymes for pesticide bioremediation;Enzymes from insects/microbes for the creation of novelchemical building blocks; Cro product protection - noveltechnologies for the control of insect & pest infestation.

CSIRO - Centre for Mediterranean AgriculturalResearchPrivate Bag No. 5Wembley 6913WESTERN AUSTRALIATel: +61 8 9333 6640Fax: +61 8 9333 6410

Senior Contact: Dr James Ridsdill-SmithPosition:Email: james.ridsdill-smith@csiro.au

CSIRO Land and WaterUnderwood AvenueFloreat 6014WESTERN AUSTRALIATel: +61 8 9333 6306Fax: +61 8 9333 6306Web: www.clw.csiro.au

Senior Contact: Dr Peter FranzmannPosition: Theme Leader - BiogeotechnologyEmail: peter.franzmann@csiro.au

Company OverviewProvide biophysical research and development andsocial and economic analysis for sustainable use ofresources, especially in water use and reuse, landscapesystems, environmental contaminants and remediation,farming systems, tropical land and water management,irrigation, catchment management and social aspectsof natural resource management.

Product InformationIn the biotechnology area in Western Australia,research and development concentrates on mining

biotechnology, potable water treatment biotechnology,bioremediation, and biological treatment of industrialwaste.

CSIRO - Livestock Industries - MediterraneanLivestock Systems (MLS)Private Bag 5Wembley 6913WESTERN AUSTRALIATel: +61 8 9333 6000Fax: +61 8 9387 8991Web: www.csiro.au/mls

Senior Contact: Dr Anton CoppensPosition: Business Development OfficerEmail: anton.coppens@csiro.au

Company OverviewThe Commonwealth Scientific Research Organisation(CSIRO), Division of Livestock Industries is representedby the Mediterranean Livestock Systems (MLS)program in Western Australia.The MLS program undertakes research and providesexpert services for livestock and allied industries for allthe Southern agricultural regions of Australia.

Product InformationREDUCING ENVIRONMENTAL IMPACT - TheReducing Environmental Impact sub-programaddresses two serious environmental challenges facingAustralia’s agricultural industries: landscape changedue to increasing salinity and climate change due togreenhouse gas production.Projects include:• Sustainable grazing of saline land - Innovative

livestock solutions for saline/waterlogged land thatcontribute to the sustainable development ofagricultural industries and rural communities.

• Rumen manipulation by vaccine technology -Developing vaccines to promote animal growth whilereducing environmental impact from cattle andsheep for Australia’s livestock industries.

Contact: Dr David Masters, Tel: (08) 9333 6691, Email:David.Masters@csiro.au

GREATER PRODUCTIVITY - The Greater Productivitysub-program aims to enhance the viability andsustainability of Australian agriculture by providingtimely and accurate information and know-how thatrevolutionises daily on-farm management decisions.Projects include:• Pastures from space - Near-real time delivery of a

suite of information tools at a whole-farm and withinpaddock level that will underpin tactical and strategicdecision making.

• Quantitative specification of feed for animalproduction - Feeding value of pastures, forage andfodders.

• Decision support tools - Developing a detailedruminant model to provide advice for themanagement of animals.

Contact: Dr Dave Henry, Tel: (08) 9333 6689, Email:Dave.Henry@csiro.au

NEW AND IMPROVED PRODUCTS - The New andImproved products research program aims to develop

17

technologies to improve meat flavour, meat and milkconsumption, wool processing and garment quality inorder to meet consumer demand and future marketsfor new products and services.Projects include:Sheep for the future - Research into increase meatturnoff from medium-fine Marinos, greater discounts forfiner wool in cropping areas and a decreased ability ofanthemlmitics to deal with internal parasites.Field testing of genetically modified sheep - Monitoringmilk protein and development of sheep geneticallymodified with additional growth hormone gene in fieldconditionsImproving dairy milk protein - researching milk proteinconcentration and providing information to the dairyindustry on how to maximise milk protein content.Health fats - Investigate the introduction of healthy fats,such as Omega-3, by feeding sheep protected tunasupplement in their diet to enrich lamb meat.Contact: Dr Norm Adams, Tel: (08) 9333 6687, Email:Norm.Adams@csiro.au

CSIRO Minerals - AJ Parker CRC forHydrometallurgyThe Parker CentreLevel 3 West Wing Loneragan BuildingMurdoch UniversityMurdoch 6150WESTERN AUSTRALIA

Leaching and Biotechnology:Parker Centre (CSIRO Minerals)7 Conlon StreetWaterford 6152WESTERN AUSTRALIA

Tel: +61 8 9334 8034Fax: +61 8 9334 8001Web: www.parkercentre.crc.org.au

Senior Contact: Dr Helen WattlingPosition: Sub-Program Leader - Leaching andBiotechnology, CSIRO MineralsEmail: helen.watling@csiro.auCompany OverviewThe AJ Parker CRC for Hydrometallurgy (the ParkerCentre) was established in 1992 in Perth (WA) underthe Australian Government’s CRC Program. In 1999, itsresearch and technology transfer successes gained theParker Centre a second seven years of funding ($18.5million in total) from the CRC Program. The current corepartners in the Centre are CSIRO Minerals, CurtinUniversity, the Department of Mineral and PetroleumResources (WA), Murdoch University, the University ofQueensland, eleven major mineral processingcompanies and AMIRA International. From a smallgroup of researchers working in different organisationswith limited collaboration in 1992, the Parker Centre hasgrown to become Australia’s largest hydrometallurgicalresearch organisation. It is a major asset for Australia’sminerals industry.

Product InformationThe Centre’s research aims to optimise the performanceof existing hydrometallurgical plants by increasing

efficiency, yield and productivity and minimising costs,whilst not ignoring the opportunity to develop newprocesses. In particular the Leaching and Biotechnologygroup are the largest research team in the public domainfocused upon improving mineral processingbiotechnology.

CSIRO Petroleum26 Dick Perry AvenueKensington 6151WESTERN AUSTRALIATel: +61 8 6436 8661Fax: +61 8 6436 8555

Senior Contact: Mr Darran CareyPosition: Systems AdministratorEmail: darran.carey@csiro.au

Curtin University - Department ofEnvironmental BiologyKent StreetBentley 6102WESTERN AUSTRALIATel: +61 8 9266 7041Fax: +61 8 9266 2495

Senior Contact: Prof. Jonathon MajerPosition: Head of SchoolEmail: J.Majer@curtin.edu.au

Company OverviewThe Department of Environmental Biology falls withinthe Division of Engineering and Science at CurtinUniversity of Technology. It has 8 academic staff, 25adjunct academic staff and 10 support staff. Currently,there are 158 undergraduate students and 33postgraduate students.

Product InformationThe Department of Environmental Biology aims todevelop in its students a thorough understanding of thebiological principles and practices, and to enhance thecapacity of its graduates and other members of thecommunity to solve environmental problems. In doingso, it is committed to the innovative application oftechnology, a cultivation of responsive and responsiblelinks to the wider community, and the development ofits students and staff as informed citizens of the world.In order that its mission might be realised, theDepartment of Environmental Biology has set itself fourmajor goals:• To achieve excellence in teaching and learning by

encouraging and supporting the scholarly,professional and personal development of staff andstudents, such that graduates can become valuablemembers of the Australian and internationalcommunities. (Teaching and Learning);

• To advance the theoretical and practicalcompetence of students and staff by encouragingand supporting the involvement of these people ina variety of research and consultancy activities inassociation with government, industry and otherinstitutions. (Research and Development);

• To enhance the general awareness andunderstanding of environmental matters by sharing

18

knowledge, expertise and resources that areavailable within the Department and with sectors ofthe university and the wider community. (CommunityService); and

• To facilitate the efficient and effective operation ofthe Department and its members by thedevelopment and periodic evaluation ofmanagement systems and procedures. (Qualityand Leadership).

Curtin University - School of Biomedical ScienceKent StreetBentley 6102WESTERN AUSTRALIATel: +61 8 9266 7375Fax: +61 8 9266 2342Web: www.biomed.curtin.edu.au

Senior Contact: Dr Robert DunstanPosition: Head of SchoolEmail: R.Dunstan@curtin.edu.au

Company OverviewThe School of Biomedical Sciences is one of sevenschools in the Division of Health Sciences at CurtinUniversity. The Division is the largest of its kind inAustralia, offering more than seventy courses, fromAssociate Degrees to Doctoral programs. The Schoolis large, complex and diverse, with a high research /consultancy profile. It is involved in the education andtraining of medical and biomedical scientists andtechnicians across eight major disciplines - microbiology,biochemistry, molecular biology, immunology,haematology, diagnostic cytology, histopathology andhuman biology - each a field in its own right. It alsoprovides service teaching programs in human biologyand microbiology and is involved in the training of dentalhygienists.

CustomVis (CLVR Pty Ltd)PO Box 518Balcatta 6914WESTERN AUSTRALIATel: +61 8 9240 7373Fax: +61 8 9240 7375Web: www.customvis.com

Senior Contact: Mr Paul Van SaarloosPosition: Chief Executive OfficerEmail: paulvs@customvis.com

Company OverviewCustomVis designs and globally markets customisedsurgical laser vision cirrection equipment, including solidstate refractive lasers as well as associated diagnosticsequipment which measure the visual pathways of theeye.

Department of Agriculture3 Baron Hay CourtSouth Perth 6155WESTERN AUSTRALIATel: +61 8 9368 3459Fax: +61 8 9367 7389Web: www.agric.wa.gov.au

Senior Contact: Ms Nicole FernandesPosition: Biotechnology Liaison OfficerEmail: nfernandes@agric.wa.gov.au

Company OverviewThe Department of Agriculture, Western Australia hasbeen involved in biotechnology research for many yearsand believes that biotechnology offers significantbenefits for producers, the food manufacturing industryand consumers. The Department has achievedsignificant success in molecular plant breeding over anumber of years. The technologies developed by theDepartment have also been applied to animal healthissues resulting in major improvements in that area.This experience and expertise supports theDepartment’s interest in, and commitment to, furtherresponsible development and application of agriculturalbiotechnology.

Department of Conservation and LandManagement17 Dick Perry AvenueWestern Precinct Technology ParkKensington 6151WESTERN AUSTRALIATel: +61 8 93340463Fax: +61 8 93340466Web: www.calm.wa.gov.au

Senior Contact: Dr Neil BurrowsPosition: Director, Science Division

DNA-ID Labs Pty Ltd272 Cambridge StreetWembley 6014WESTERN AUSTRALIATel: +61 8 9284 9662Fax: +61 8 9284 0211Web: www.dna-id.com.au

Senior Contact: Mr John WetherallPosition: DirectorEmail: susan@dna-id.com.au

Company OverviewDNA-ID LABS is located in Perth, Western Australia.Our laboratory is electronically protected for security andequipped with modern technology for performing DNApaternity testing. Our professional staff have a combinedexperience in DNA technology and parentage testingof over 20 years and pioneered some of the initialapplications of DNA profiling in Australia.

Product InformationDNA-ID LABS is an industry leader in the developmentand implementation of innovative technology. Throughcontinued research and development of DNAtechnology, coupled with excellent laboratory practices.This commitment to quality ensures that we can provideyou with reliable results at competitive fees. DNA-IDLABS services include standard parentage testing and

19

the collection of tissue samples.

Eastland Medical Systems LimitedUnit 6, Level 2680 Murray StreetWest Perth 6005WESTERN AUSTRALIATel: +61 8 9481 1844Fax: +61 8 9486 4998Web: www.eastlandmedical.com

Senior Contact: Don O’SullivanPosition: Chief Executive OfficerEmail: don.osullivan@eastlandmedical.com

Company OverviewEastland Medical Systems Limited is an Australianbased company that provides a comprehensive rangeof affordable injection, infusion and blood drawingdevices to protect healthcare workers from needlestickinjury and creat a safe workplace environment.

ENT Technologies Pty Ltd18 Emander DriveDianella 6059WESTERN AUSTRALIATel: +61 8 9375 9944Fax: +61 8 9375 9966

Senior Contact: Dr Sam BarbalattPosition: Medical DirectorEmail: sue@fyi.com.au

Company OverviewPharmaceutical and instrument/device specialisation inthe field of Ear, Nose and Throat Medicine. ENTTechnologies is a small organisation, with excellentlinkages to leading ENT investigative units in Australia.

Product InformationNatural medicine for healing of damage nasal tissuesand for the relief of Perennial Non Allergic Rhinitis, NasalPolyps and Allergic Rhinitis. Nasal anaesthetic andvasoconstrictor for preparation of nasal tissue forendoscopy. Exciting research projects underway intomembrane altering of Pseudomonas species.

Environmental Solutions International Ltd21 Teddington RoadBurswood 6100WESTERN AUSTRALIATel: +61 8 9470 4004Fax: +61 8 9355 0450Web: www.environ.com.au

Senior Contact: Mr Graeme AndersonPosition: Business Development ManagerEmail: graemea@environ.com.au

Company OverviewESI is a process and contract delivery group thatprovides practical solutions for water and wastetreatment, using processes at the forefront of today’stechnologies. The company has developed and

commercialised technologies to address a number ofwaste management issues, including domestic wastes,high strength wastes and biosolids. These technologiesmaximise the use of biological processes and therecovery of energy and useful by-products whileminimising the use of chemicals.

Product InformationESI has developed and commercialised a suite ofinnovative water and wastewater treatment processescapable of providing high efficiency treatment of highlypolluted, organic aqueous mixtures from industrial,municipal and domestic sources.

Environmental Technology CentreSouth StreetMurdoch 6150WESTERN AUSTRALIATel: +61 8 9360 7310Fax: +61 8 9360 7311Web: http://wwwies.murdoch.edu.au

Senior Contact: Dr Martin AndaPosition: Research ManagerEmail: etc@murdoch.edu.au

Company OverviewThe Environmental Technology Centre (ETC) at MurdochUniversity is the United Nations EnvironmentProgramme International Environmental TechnologyCentre (UNEP-IETC) Asia Pacific Cooperation ResearchCentre. The ETC’s research program includes projectsin the areas of water, food, energy, shelter, and materialresources, with an emphasis on the integration of theseareas to achieve sustainability.

EQiTXPO Box 1592West Perth 6872WESTERN AUSTRALIATel: +61 8 9480 0490Fax: +61 8 9480 0452Web: www.eqitx.com

Senior Contact: Dr Noel ChambersPosition: Chief Executive OfficerEmail: info@eqitx.com

Company OverviewEQiTX has an interest in the field of biotechnologyresearch and its outcomes, as can be applied to ouraging population. As our generations age, many chronicailments will affect our current lifestyles. Hence, EQiTXis seeking to acquire technology at different stages ofscientific development that will aid in the maintenanceand/or improvement of human health for generationsto come. The main areas of interest are humantherapeutics and diagnostics associated with chronicillnesses, such as Alzheimer’s Disease, Cancer,Diabetes and Cardiovascular Disease.

Product InformationIn December 2002 EQiTX signed a heads of agreementto acquire the Gingerol project – its first investment underthis model. The technology was developed in the School

20

of Pharmacy at The University of Sydney, whereProfessor Basil Roufogalis and his team isolated andsubsequently synthesised new active analogues froman extract of the plant, Zingiber officinale. These newcompounds may have advantages over conventionaltherapies in the use of chronic peripheral and sensorypain. These compounds may also offer new treatmentsfor diseases causing inflammation such as arthritis,where current drugs have significant safety concerns.The Gingerol project has novel potential drugs basedon Ginger and Capsaicin and these are being developedfor the management of pain and inflammation. Thesecompounds, based on the active constituents of plantswith traditional use in inflammatory and painfulconditions, have been shown to be vanilloid receptorantagonists as well as COX-1 and COX-2 antagonists.Compounds binding to vanilloid receptors represent apromising new approach for the development of novelanalgesics whilst compounds inhibiting COX-1 and COX-2 are known to reduce inflammation. Initial animalstudies have confirmed the positive pharmacologicalactivities of the lead compounds in models ofinflammation and pain. They are also less pungent thancapsaicin and initial toxicity studies have revealed noobserved side effects on acute administration.Furthermore, the lead compound has demonstratedcomparable, if not better pain management effects(analgesia) than morphine without indications oftolerance and dependence identifying a potential clearmarket advantage.

Fisher Biotec Pty Ltd14A Brennan WayBelmont 6104WESTERN AUSTRALIATel: +61 8 180006 6077Fax: +61 8 9479 5396Web: www.fisherbiotec.com

Senior Contact: Mr Chris FisherPosition: DirectorEmail: chris@fisherbiotec.com

Company OverviewFisher Biotec is an innovative 100% Australian companyfounded in 1996 by a group of key molecular biologists.The staff of Fisher Biotec have international experiencein both research and commercial development ofproducts designed to solve research problems and helpto diagnose health disorders. We aim to add value tomolecular biology research and diagnostics by creatinginnovative and cost effective solutions to commonresearch problems. Fisher Biotec is a supplier of leadingbrands of molecular biology and diagnostic researchequipment, reagents, and services helping to keepAustralian researchers at the cutting edge of researchin these areas.

Product InformationFisher Biotec carries a wide range of scientific researchequipment and is an Australian licenced manufacturerof molecular biology products for research and

diagnostic applications for a full product range refer toour web site at www.fisherbiotec.com

Fisheries Management Services3rd Floor, SGIO Atrium168-170 St Georges TcePerth 6000WESTERN AUSTRALIATel: +61 8 9482 7333Fax: +61 8 9481 3576Web: www.fish.wa.gov.au

Senior Contact: Mr Peter MillingtonPosition: DirectorEmail: pmillington@fish.wa.gov.au

Company OverviewThe Department of Fisheries has developed world-classsystems for ecologically sustainable management oftropical and warm temperate fisheries.The components of the Western Australian fisheriessystem include: Biological research, Fish stockassessment and modelling, Fishing effort and catchquota management plans, Fish habitat protectionsystems, Licensing systems, Legislation development,Monitoring control and surveillance, Communityeducation and training, Fisheries extension, Indigenouscommunity development, Aquaculture research anddevelopment, Seafood handling and marketing, andFish health.The Department can provide advice on these aspectsof fisheries management and development, and isdeveloping a capacity to extend this expertise to othercountries, particularly in the Indian Ocean region.

Product InformationThe Department is responsible for the administrationof the Fish Resources Management Act 1994, underwhich permission must be obtained to take marineorganisms for commercial purposes.

Fluid System Technologies (WA)PO Box 1255Booragoon 6954WESTERN AUSTRALIATel: +61 8 9331 1111Fax: +61 8 9331 3223Web: www.swagelok.com/industry/bio/

Senior Contact: Mr Paul BlakemorePosition: Managing DirectorEmail: paul.blakemore@fstech.com.au

Company OverviewDistributor of biopharmaceutical and pharmaceuticalmanufacturing process line components andinstrumentation for Western Australia, South Australiaand Northern Territory.

Product InformationBPE grade and higher tubular fittings, valves, filters,tubing etc. Brand names - JENSEN and SWAGELOK

21

FOSS Pacific Pty LtdPO Box 218Kingsway 6065WESTERN AUSTRALIATel: +61 8 0438 698 959Fax: +61 8 9302 4222Web: www.foss.dk

Senior Contact: Mr Peter DarchPosition: Account Manager (WA & SA)Email: pdarch@foss.com.au

Company OverviewFOSS provides and supports dedicated, rapid andaccurate analytical solutions, which analyse and controlthe quality and production of agricultural, food,pharmaceutical and chemical products to theenhancement of our customer’s business.

Product InformationNIR analysers, FTIR analysers, Automated Kjeldahl,Automated Soxhlet, Automated Fibre, Milk analysis,Beer analysis, Wine analysis, Grain analysis, Meatanalysis, Flow Injection analysis, Rapid Microbiologyanalysis, GMO analysis, Fat analysis by SFX, On-lineProcess control in polymer, chemical, petrochemical,textile, pulp and paper, pharmaceutical, and dairyindustries.

Fremantle Hospital Medical ResearchFoundationPO Box 480Fremantle 6959WESTERN AUSTRALIATel: +61 8 9431 2106Fax: +61 8 9431 2576

Senior Contact: Ms Angie LydallPosition: ManagerEmail: Angie.Lydall@health.wa.gov.au

Company OverviewPrimarily the Foundation’s role is to fund annual“seeding” medical research grants (to a max. of $10,000each) for Fremantle-hospital-based researchers. TheFoundation is a Private Trust, and a separate entity toFremantle Hospital and Health Service.

Product InformationThe Foundation employs no scientific/medical staff andhas no research facilities of its own. Researchers whoreceive grant funds use the existing facilities of thehospital - labs etc.

Gene Stream Pty Ltd96 Chipping RoadCity Beach 6015WESTERN AUSTRALIATel: +61 8 9205 1149Fax: +61 8 9205 1149Web: www.genestream.com.au

Senior Contact: Dr John DalyPosition: Managing Director

Email: johndaly@bigpond.net.au

Company OverviewGene Stream Pty Ltd is a start-up biotechnologycompany aimed at developing improved DNA-basedtools for medical research and in particular, drugscreening. Gene Stream Pty Ltd has developed noveland improved technologies with applications in pre-clinical drug screening.

Product Information• Improved reporter systems that more accurately

measure changes in gene expression. For example,before and after treatment of cells or mice with arange of drug candidates.

• Transgenic mice that more accurately predict thelikely effect of drugs in humans.

Genesis Biomedical Ltd2nd Floor, 464 Hay StreetSubiaco 6008WESTERN AUSTRALIATel: +61 8 9388 8322Fax: +61 8 9388 9203Web: www.genbiomed.com

Senior Contact: Mr Wayne KernaghanPosition: Chief Financial OfficerEmail: rnorthcott@genbiomed.com

Company OverviewGenesis Biomedical Ltd is an innovative medicaltechnology company that utilises its Intellectual Capitalbase in a systematic way to develop value addedproducts and processes that are commercialised throughstrategic channel partners in well-definedmusculoskeletal market segments.

Product InformationThe Company’s core technologies include smart cardcontrolled and internet enabled innovations for thebiomedical market. Genesis has developed its owntechnology portfolio of products and processes and usespartnering to share in the benefits of providing theseinnovations to ensure competitive advantage in relatedfields.

Go Medical Industries Pty Ltd200 Churchill StreetSubiaco 6008WESTERN AUSTRALIATel: +61 8 9388 1700Fax: +61 8 9382 4952Web: www.gomedical.com.au

Senior Contact: Mrs Patsy GraiegPosition: Chief Executive OfficerEmail: info@gomedical.com.au

Company OverviewGo Medical Industries has the world’s most extensiverange of disposable pain management products. Wehave devices for intravenous, epidural, intranasal, andsubcutaneous use.

Product InformationProduct range include the pain management device

22

Springfusor, infusion pumps, obs/gyn, nasogastricfeeding device, IV connectors and urology devices.

Grain Biotech Australia Pty LtdPO Box 44Bullcreek 6149WESTERN AUSTRALIATel: +61 8 9360 7561Fax: +61 8 9360 7569Web: www.grainbiotech.com

Senior Contact: Dr Ian EdwardsPosition: Chief Executive OfficerEmail: info@grainbiotech.com

Company OverviewGrain BioTech Australia Pty Ltd (GBA) is Australia’s firstprivate wheat breeding company that fully integratesmolecular biology with applied plant breeding to produceproducts with added value for the Australian andinternational markets. Founded in 1998, the companylaunched its first three wheat varieties in 2003, and willbe field testing its first three GM traits (Barley YellowDwarf Virus resistance; antioxidant; and salt tolerance)in 2004.

Product InformationWheat transformation; High quality wheat varieties;BYDV Resistance; Modified starch lines; Salt tolerance;International germplasm base; Antioxidant Molecularmarkers; Marker gene; Doubled Haploid system (in-house); Promoters; Pharmaceutical productdevelopment

Gray Surgical24 Brodie Hall DriveBentley 6102WESTERN AUSTRALIATel: +61 8 9355 3777Fax: +61 8 9355 3788

Senior Contact: Dr Bruce GrayPosition: Managing DirectorEmail: gray@graysurgical.com

Company OverviewDesign and manufacture of Surgical Retractor System

Product InformationThese systems are designed by Gray Surgical for useby surgeons in respect of General Abdominal and LowerPelvic Surgery, hip Surgery, Urology Surgery and GastricBypass surgery for morbidly obese patients.

Ibis Technology24/70 Roberts StreetOsborne Park 6017WESTERN AUSTRALIATel: +61 8 9443 9121Fax: +61 8 9443 9115

Web: www.ibistechnology.com.auSenior Contact: Mr Craig SissonPosition: Chief Executive OfficerEmail: csibis@space.net.au

Company Overview

Ibis Technology offers a wide range of products andservices in the field of laboratory water purification,filtration, ultrafiltration, cell culture, fermenters andproteomics. Ibis Technology manufacturers waterpurification systems as well as distributing the Elgarange of laboratory water systems. Ibis Technology isalso the Western Australian distributors for Sartotiusfiltration and Vivascience. Sartorius is also the parentcompany for Braun fermenters.

Product Information1) Water purification; 2) Filtration/Ultrafiltration; 3) Cellculture; 4) Fermenters; 5) Proteomics

ID + Plus Ltd328 Aberdeen StWest Perth 6005WESTERN AUSTRALIATel: +61 8 9422 1127Fax: +61 8 9384 8840Web: www.idplus.com.au

Senior Contact: Mr Pat CarnegiePosition: ChairmanEmail: carnegie@bias.net.au

Company OverviewID+Plus is developing and commercialising its productsin the fields of individual livestock identification, SNiP-SCAN™ and DNA Analysis, with the ReporterChip™ .

In Vitro Laboratories Pty LtdPO Box 966Subiaco 6094WESTERN AUSTRALIATel: +61 8 9382 2388Fax: +61 8 9381 3603

Senior Contact: Dr Bruce BellingeEmail: bruce@conceptfert.com.au

Company OverviewDiagnostic Services

Inner Vision Biometrics Pty Ltd30 Ord StreetWest Perth 6005WESTERN AUSTRALIATel: +61 8 9380 1138Fax: +61 8 9380 1014

Senior Contact: Mr Paul ClarkPosition: DirectorEmail: clark@physics.uwa.edu.au

Company OverviewInner Vision Biometrics Pty Ltd is a start-up companythat is commercialising a patented method formeasuring and imaging proton relaxation rates in thehuman body using magnetic resonance. A majorapplication of the technology is the non-invasivemeasurement and imaging of tissue iron concentrationsin patients with iron metabolism disorders. IVB iscurrently establishing a service facility in Perth for theremote analysis of magnetic images, and thus cater to

23

the global community of people affiliated with irondisorders.

Integra Management Pty LtdSuite 610 Mary StreetComo 6152WESTERN AUSTRALIATel: +61 8 9367 8222Fax: +61 8 9367 2322Web: www.ehci.com.au

Senior Contact: Mr Brian HigsonPosition: DirectorEmail: brianh@ehci.com.au

Company OverviewIntegra Management is involved in the formulation,manufacture and distribution of a range of commercialproducts for the degradation of organic waste streams.Through the combination of microbial biotechnology,plant based micelle and micro-emulsion surfactants,Integra Management provide a range of environmentallysafe and safe to use commercial cleaning products.

Product InformationIntegra Management commercialise leading technologyby the development of high performance, lowenvironmental impact products. All of the raw materialsused in our products are from renewable resources.

Keogh Institute for Medical ResearchSir Charles Gairdner HospitalVerdun StreetNedlands 6009WESTERN AUSTRALIATel: +61 8 93462008Fax: +61 8 93463003

Senior Contact: Dr Bronwyn StuckeyPosition: Medical DirectorEmail: rmri@wt.com.au

Company OverviewThe Institute was founded in 1983 as the ReproductiveMedicine Research Institute by the late Clinical AssociateProfessor, Ted Keogh. Renamed in his honour, it retainsits focus on the wider aspects of male and femalereproductive function. It is a non-profit, privately fundedbody, concentrating on research and research basedtreatment.The Keogh offers Doctors and their patients a centre ofexcellence, with skills and experience across a widerange of disciplines, to ensure proper, prudent treatment.

Product InformationCurrent Research and treatment programmes include:male ageing, male menopause, male hormonereplacement, impact of prostate disease andcardiovascular health, prevention of osteoporosis,preventing impotence in diabetes, female sexualdysfunction, developing hormone replacement therapymethods, body weight effect on reproduction and viceversa, safe treatment of infertility, thyroid malfunctionpost pregnancy, diagnosis and treatments, polycysticovarian syndrome, new treatments for premature

ejaculation, and vascular function in post menopausalwomen.

Kestral ComputingSuite 8137-141 Main SttreetOsborne Park 6017WESTERN AUSTRALIATel: +61 8 9202 5555Fax: +61 8 9202 5599Web: www.kestral.com.au

Senior Contact: Ms Melissa HerronPosition: National Support ManagerEmail: melissah@kestral.com.au

Company OverviewKestral Computing is a United, Spirited Team of 30 ITHealth Professionals including 14 Programmers, 11Support Personnel, Administration and Management.A Creator and Implementor of Innovative MedicalDiagnostic Information Systems. Software suppliers forpathology and radiology services within Australia andAsia. Kestral Computing are currently working on avariety of projects from 32bit windows applications tofull GVI applications. Other current projects are HL7electronic order entry, increased HL7 PACS integrationand further HL7 to voice recognition system interfaces.

Lawley Pharmaceuticals Pty Ltd672 Beufort StreetMt Lawley 6050WESTERN AUSTRALIATel: +61 8 9371 9524Fax: +61 8 9371 7853Web: http://www.lawleypharm.com.au

Senior Contact: Mr Micheal BuckleyPosition: General ManagerEmail: lawleyph@arach.net.au

Company OverviewLawley Pharmaceuticals makes quality pharmaceuticalhormone creams containing the naturally producedhormones testosterone, progesterone and oestradiol.

Product InformationLawley Pharmaceuticals produce a male testosteronecreams, Andromen® and Andromen® Forte, andfemale progesterone cream, Pro-Feme®

Lions Cancer Institute (Inc)c/o Royal Perth HospitalMurray StreetPerth 6000WESTERN AUSTRALIATel: +61 8 9334 0323Fax: +61 8 9457 4144

Senior Contact: Prof Peter LeadhamPosition: Medical Director

24

Email: peterl@cyllene.uwa.edu.au

Lions Ear and Hearing InstituteGround Floor, E BlockSCGH, Hospital AvenueNedlands 6009WESTERN AUSTRALIATel: +61 8 9346 3633Fax: +61 8 9346 3637Web: www.lehi.com.au

Senior Contact: Prof Marcus AtlasPosition: DirectorEmail: marcus.atlas@health.wa.gov.au

Company OverviewThe Lions Ear and Hearing Institute is a recentlyestablished centre of excellence dedicated to high qualityclinical care, diagnosis, surgery and research in all areasof ENT. The Institute has a research team of scientists,clinicians and students engaged in various researchprojects. These cover the fields of telemedicine, imageprocessing and analysis, tissue engineering, audiologyand clinical governance.

Lions Eye Institute of Western Australia Inc.2 Verdun StreetNedlands 6009WESTERN AUSTRALIATel: +61 8 9381 0777Fax: +61 8 9381 0700Web: www.lei.org.au

Senior Contact: Professor Ian ConstablePosition: DirectorEmail: ijc@cyllene.uwa.edu.au

Company OverviewThe Lions Eye Institute (LEI) is the largest eye researchorganisation in the southern hemisphere. Affiliated withthe University of Western Australia, LEI is recognisedas one of the world’s pre-eminent eye researchinstitutes that combines fundamental science withclinical interactions and is dedicated to the investigation,prevention and cure of blinding eye disease. Researchis directed to the prevention and treatment of glaucoma,diabetes related blindness, age-related maculardegeneration, retinal diseases and corneal conditions.Over 40,000 patients from within Australia and the AsiaPacific access LEI’s day surgery and clinic servicesand nearly 3,000 major eye operations are performedeach year. LEI generates a critical mass of researchfocussing on the eye. Employing over 100 medicalresearchers, scientists, biomedical engineers anddoctors recruited from over 30 countries, LEI’sprogrammes range from basic science through tocommercialisation of R&D.

Product InformationSignificant technological achievements include:• LEI, in conjunction with Argus Biomedical Pty Ltd

(established to develop and market the outputs ofLEI’s research effort), developed AlphaCor™, theworld’s first soft artificial cornea.

• A $2.63 million joint USA and Australian grant for aresearch project ‘Gene-based Treatment Strategies

for Diabetic Retinopathy’.• Development of an internationally acclaimed

telemedicine system that enables images of the eyeto be captured and transmitted securely bytelephone or the internet.

• A robotics ultra-microsurgical system, in itsadvanced stages will allow major new 21st centurysurgical treatments that are currently limited by thetremor of a surgeon’s hand to be performed.

MedicVision Limited85 The EsplanadeSouth Perth 6151WESTERN AUSTRALIATel: +61 8 9368 0889Fax: +61 8 9368 4809Web: www.medicvision.com.au

Senior Contact: Mr Ross HorleyPosition: DirectorEmail: ross.horley@medicvision.com.au

Company OverviewMedicVision is a leader in the field of telemedicine, whichis the use of telecommunications to provide medicaleducation, information and services. The company wasthe subject of considerable attention, particularly inreference to the utilisation of elements of VolumeInteractions’ technology in the marathon operation toseparate Siamese Twins in Singapore. As aconsequence of these technologies and technicalcapabilities Medic Vision has developed significantcollaboration and alliance agreements with a number ofthe world’s leading educational facilities, medicalequipment suppliers, medical colleges, surgical skillscentres, and major pharmaceutical companies.

Microgene Pty Ltd4050 Great Eastern HwyMahogany Creek 6072WESTERN AUSTRALIATel: +61 8 9298 9990Fax: +61 8 9298 9993Web: www.microgene.com.au

Senior Contact: Dr Frank McKennaPosition: Senior Research ScientistEmail: frank@microgene.com.au

Company OverviewMicrogene is a microbiology and molecular geneticslaboratory that develops bacteria for use in agriculture,horticulture and forestry. Other departments includetissue culture, DNA fingerprinting and genetic markers,microarray development and animal health science andnutrition. Microgene is a private corporation solely ownedby scientific personnel. We have large fermentationplants in Australia and in USA and are large-scale, batch-ready for a number of project types including bacteriaproduction, metabolite extraction and enzyme productionand extraction.

25

Mount Todd Rehabilitation Project Pty Ltdc/o Micron ResearchUnit 7, 14 King Edward RoadOsborne Park 6017WESTERN AUSTRALIATel: +61 8 9204 2666Fax: +61 8 9321 7747

Senior Contact: Dr Gil StokesEmail: drstokes@iinet.net.au

Murdoch University Biotechnology ProgramMurdoch UniversitySouth StreetMurdoch 6150WESTERN AUSTRALIATel: +61 8 9360 2785Fax: +61 8 9310 7084

Senior Contact: Dr Philip O’BrienPosition: Senior Lecturer

Company OverviewBioEngineering

Newmont Yandal Operations Ltd (WilunaOperations)PO Box 9Wiluna 6646WESTERN AUSTRALIATel: +61 8 99818200Fax: +61 8 99806026Web: www.newmont.com.au

Senior Contact: Mr Tim SugdenPosition: General ManagerEmail: tim.sugden@newmont.com.au

Company OverviewNewmont Mining Corporation is the world’s largest goldproducer, with equity ounces of 7.6 million in 2002. Itsheadquarters are located in Denver, US and it hasoperations or projects in 11 countries. Newmont YandalOperation is a wholly owned company that operatesthe Wiluna, Bronzewing and Jundee mines in WesternAustralia.

Product InformationThe Wiluna Operation produces approximately 120,000ounces of gold per annum. Ore is mined mainly fromunderground sources. Ore passes through a milling andflotation circuit to produce a sulphide concentrate thatcontains around 100 g/t Au. The concentrate is oxidisedusing Biox technology and the resulting slurry is leachedusing conventional CIL technology. Gold recovery isapproximately 85%.

Orion Laboratories Pty Ltd85 Briggs StreetWelshpool 6106WESTERN AUSTRALIATel: +61 8 94723844Fax: +61 8 94703360Web: www.orion.net.au

Senior Contact: Mr Robert KimptonPosition: Managing DirectorEmail: orion@iinet.net.au

Company OverviewORION Laboratories Pty Ltd is a privately ownedAustralian company based in Perth, Western Australiaand was founded in 1985. The company has since grownrapidly into one of Australia’s emerging pharmaceuticalmanufacturers and suppliers, particularly to hospitals.Markets include Australia, New Zealand, South East Asiaand several other export destinations.The company holds a Therapeutic Goods Administration(TGA) licence to manufacture, package and store non-sterile & terminally sterilised medicinal products forhuman use, and a Australian Pesticides and VeterinaryMedicines Authority (APVMA) manufacturing licence forCategory 2 & 4 veterinary products. Contractmanufacturing is conducted for these types of productsin addition to cosmetics and industrial cleaning agents.There are up to 60 full-time employees on site who areengaged in production, quality assurance/control,warehousing and distribution, maintenance andadministration, with sales representation within Australiaand the Asia Pacific region.

Product InformationThe company manufactures and markets an extensiverange of non-sterile and terminally sterilised ORIONbranded products including therapeutic pharmaceuticalssuch as drugs, over-the-counter medicines, formulateddevices and disinfectants. Dosage forms include liquids,creams, suppositories and pessaries.An extensive contract manufacturing service is alsoprovided to customers for therapeutic goods, veterinaryproducts, cosmetics and industrial cleaning agents.Technical and regulatory support can also be providedas part of this service.

Ozgene Pty LtdPO Box 1368Canning Vale 6970WESTERN AUSTRALIATel: +61 8 9312 3222Fax: +61 8 9310 2839Web: www.ozgene.com

Senior Contact: Mr Eddie NoonanPosition: Business Development ManagerEmail: enoonan@ozgene.com

Company OverviewOzgene is an Australian company that producesgenetically modified (GM) Mice and Rats for globalmarkets. GM Mice and Rats are currently the only animalmodels allowing researchers to precisely mimic humanconditions of genetic disorders on a molecular level. GMMice & Rats represent the most sophisticated andvaluable tools in Functional Genomics and Drug TargetValidation.Ozgene was founded in 1999 by Director and ChiefExecutive Officer Dr Frank Koentgen. Dr Koentgen hasmore than 15 years international experience in themanagement and production of GM mice. He formerlyestablished and headed the Genetically Modified MouseLaboratory at the Walter and Eliza Hall Institute (WEHI)

26

in Melbourne and previously provided GM mouseservices at Roche Pharmaceuticals. Dr Koentgen haspublished his work in scientific journals such as Nature,Science, Immunity, PNAS, Nature Medicine and manyothers.Ozgene’s Chief Executive Officer is supported by aninternationally experienced Board of Directors. Themembers include: Dr Zisi Fotev (Atugen, Germany),Philip Mendes (Mendes Technology Law, Brisbane), DrKevin Fahey (Kevin Fahey & Associates, formerlyExecutive Director of Pfizer, USA). Ozgene’s seniormanagement, with Chief Scientific Officer Dr Gabi Suessand Business Development Manager Eddie Noonan,significantly expanded the international customer basein the past year. Ozgene has achieved positive cashflow and continues to grow its global business in theGM animal markets. New research and productionfacilities at Technology Park, Bentley, WA are currentlyunder development.

Product InformationOzgene’s GM animal model services include -• Design & Construction of Gene Targeting & Lentiviral

Transgenic Vectors,• Generation of Knockout, Knockin & Humanised

Mice,• Generation of Lentiviral Transgenic Mice & Rats,• Maintenance & Cryopreservation of GM Mice & Rats,

and• Phenotypic analysis of GM Mouse & Rat models .Ozgene specialises in the generation of GM mice usingits C57BL/6 murine embryonic stem cells. Ozgene’sChief Executive Officer was the first in the world toproduce such C57BL/6 Knockout mice in the early ‘90s.Embryonic stem cells from BALB/c and 129/SvJ are alsoavailable.Ozgene has the world exclusive license for theproprietary TranzEmbryo™ lentiviral technology. Thisrevolutionary TranzEmbryo™ technology was co-developed with Tranzyme Inc (Alabama, USA).Ozgene has developed the proprietary OzMousedatabase system. OzMouse allows efficient production,analysis and regular customer updating of all GM mouseand rat projects from receiving an order to productshipment. Ozgene’s customers and strategic partnershave online access to their data and results.

Pacific Ore Technologies Australia Pty Ltd1st Floor24 Outram StreetWest Perth 6005WESTERN AUSTRALIATel: +61 8 9481 6040Fax: +61 8 9481 6035Web: www.titanresources.com.au

Senior Contact: Mr Colin HunterPosition: Group MetallurgistEmail: titan@titanresources.com.au

Company OverviewPacific Ore Technologies (Australia), a wholly ownedsubsidiary of Titan Resources NL, specialises in thedevelopment of bacterial leaching solutions to themining industry.

Paradigm Diagnosticsc/o School of Anatomy and Human BiologyUWA, 35 Stirling HighwayNedlands 6009WESTERN AUSTRALIATel: +61 8 9380 2983Fax: +61 8 93801051Web: www.paradign.uwa.edu.au

Senior Contact: Dr Stuart BuntPosition: Chief Executive OfficerEmail: smbunt@anhb.uwa.edu.au

Company OverviewSpin off company formed by UWA, 20% owned byMedepartner Ltd. Selling direct to general practitionersand licensing to health services.

Product InformationDevelops medical diagnostic software, medical softwareconsultancy and bespoke software development in thebiomedical sciences.

Peko Rehabilitation Project Pty LtdUnit 7, 14 King Edward RoadOsborne Park 6017WESTERN AUSTRALIATel: +61 8 9204 1016Fax: +61 8 9389 8327Senior Contact: Ms Karen McEwan

Company OverviewMineral processing and rehabilitation of mine waters,with research into bacterial leaching technology foroxidation of refractory tailings to facilitate recovery ofcobalt, copper and gold.

PerkinElmer Life and Analytical Sciences PtyLtdPO Box 1777Canning Vale 6155WESTERN AUSTRALIATel: +61 8 0418 149 170Fax: +61 8 94560363Web: www.perkinelmer.com

Senior Contact: Ms Stephanie MooreEmail: stephanie.moore@perkinelmer.com

Company OverviewPerkinElmer is a leading global provider of drugdiscovery, research, and genetic disease screeningsolutions for customers in a variety of businesses,including the academic, biotechnology, clinical, andpharmaceutical industries.

27

Perth Bone and Tissue Bank Inc.PO Box 1125Nedlands 6909WESTERN AUSTRALIATel: +61 8 9386 9300Fax: +61 8 9386 9344Web: www.bonebank.uwa.edu.au

Senior Contact: Ms Anne CowiePosition: ManagerEmail: acowie@cyllene.uwa.edu.au

Company OverviewThe Perth Bone & Tissue Bank (PB&TB) is anindependent, incorporated, charitable organisationwhich retrieves donated bone, and after extensivetesting and processing, it is stored awaiting its use in awide variety of orthopaedic procedures.Research has been an integral function of the BoneBank since its inception. We have investigated thematerial effects of radiation and demineralisation onbone; developed new implants for internal fixation ofbone transplants; a system to deliver an evendistribution of antibiotic throughout bone byiontophoresis (the passage of an electrical current), anda system of 3 dimensional modelling to aid in pelvictransplantation.Current research involves the development of aninsoluble bone gelatin (ISBG), with demonstratedosteoinductive properties, with potential commercialpotential.

Pharmacia Australia Pty Ltd15 Brodie Hall DriveBentley 6102WESTERN AUSTRALIATel: +61 8 9362 0666Fax: +61 8 9472 3577Web: www.pharmacia.com

Senior Contact: Dr Robert HeyesPosition: Plant DirectorEmail: pharmacia@pharmacia.com.au

Company OverviewAustralia is a major country for Pharmacia and thecorporation has a strong presence here, with the regionaloffice for Asia Pacific being based in Sydney. Pharmaciaemploys about 700 staff in Australia, of whom 380 arebased in our manufacturing operation in Perth. The Perthmanufacturing operation will export about $280 millionworth of highly transformed product to 62 countries in2001. The corporation has invested about $48 millionin plant and equipment in the Perth facility in the past 8years, making Australia the world leader in theapplication of “blow-fill-seal” plastic ampoule technologyto the sterile manufacture of injectable pharmaceuticals.

Phylogica Ltd100 Roberts RoadSubiaco 6008WESTERN AUSTRALIATel: +61 8 9489 7777Fax: +61 8 9489 7700Web: www.phylogica.com

Senior Contact: Dr Paul WattPosition: Director of Research and DevelopmentEmail: paulw@phylogica.com

Company OverviewPhylogica owns specialist, value-adding technologiesfor the drug discovery process.Phylogica’s technologies constitute a drug screeningplatform (called “Discriminator Blocker Trap”) and anenriched libraries of peptides (called “PhylomerLibrary”) that can be used for drug target validation andscreening and validation of drug leads.

Product InformationDiscriminator Blocker Trap - is a high throughputscreening platform enabling the isolation of blockersof high affinity and specificity to a given protein-proteindisease complex. The two features unique to thescreening technology are - the ability to discriminatebetween a disease protein-protein complex and anormal complex involving either one of the proteins inthe disease complex (resulting in drugs that havereduced adverse side effects); and the ability todistinguish blockers of different affinities, allowingselection of high affinity blockers to a given drug target.Phylomer Library is a proprietary library of potential drugleads and target validation reagents constructed froma range of fully sequenced microbial genomes. Thelibrary consists of structured peptides and is superiorto random combinatorial peptide libraries in terms of –the quality of drug leads (more stable since Phylomerpeptides are naturally coded), the complexity of library(contains 100-1000 fold more potential drug leads) andthe bioinformatic power (generated from bacterial/archaebacterial genomes for which the entire geneticcomposition is known).

ProMicro Pty Ltd31 Green RoadHillarys 6025WESTERN AUSTRALIATel: +61 8 9401 5699Fax: +61 8 9401 5900

Senior Contact: Mr Bruce ReedPosition: DirectorEmail: edreed@vianet.net.au

Company OverviewMicrobiology specialists

Proteomics InternationalLevel 21, Governor Stirling Tower197 St Georges TerracePerth 6000WESTERN AUSTRALIATel: +61 8 9214 3886Fax: +61 8 9321 4251Web: www.proteomics.com.au

Senior Contact: Dr Bill ParkerPosition: Director of Corporate AffairsEmail: info@proteomics.com.au

28

Company OverviewProteomics International is a drug discovery andtechnical service company offering opportunities inproteomics and bioinformatics. It uses state of the artmass spectrometric and computing methods.

Product InformationProteomics International offers services in PeptideSynthesis, Peptide Analysis, Protein Analysis, and 2Dgel electrophoresis.

pSivida LtdLevel 12, BGC Centre28 The EsplanadePerth 6000WESTERN AUSTRALIATel: +61 8 9226 5099Fax: +61 8 9226 5499Web: www.psivida.com.au

Senior Contact: Mr Gavin RezosPosition: Managing DirectorEmail: psivida@psivida.com.au

Company OverviewpSivida Limited is an Australian listed public company(ASX:PSD) that is committed to the biomedicalnanotechnology sector. The company has concentratedon the development of nano-structed porous silicon(BioSilicon™) through its UK operating subsidiary,pSiMedica Limited. Whilst there are multiple potentialapplications for BioSilicon™ in human and animalhealthcare, pSiMedica has as its core focus slowrelease drug delivery and brachytherapy. pSivida’s jointventure partner in pSiMedica is the United KingdomGovernment Research and Development Agency,QinetiQ Group plc (formerly DERA).

Product InformationBioSilicon™ is a biodegradable, bioactive andbiocompatible form of silicon, which dissolves in the bodyto become silicic acid, the most common form of whichis found in everyday foodstuffs. BioSilicon™ retains thekey semiconductor properties of silicon, but is alsomachineable at a micro level, and is created through aphysical change in the silicon at the nano level, asopposed to a chemical change. BioSilicon™ is anelement, not a compound, and the resultant poroushoneycomb structure from physical nanostructuringmimics porous membrane structures found in nature.As a true platform nanotechnology, BioSilicon™ hasmultiple potential applications in healthcare. Near termapplications include slow release drug delivery,brachytherapy (targeted in-situ cancer therapies),conventional vaccine and DNA vaccine delivery,orthopaedics and tissue engineering.

Raine Medical Research FoundationSuite 24, Hollywood Specialist Cente95 Monash AvenueNedlands 6009WESTERN AUSTRALIATel: +61 8 9386 9880Fax: +61 8 9386 9522Web: www.raine.uwa.edu.auSenior Contact: Ms Lyn Ellis

Position: Executive OfficerEmail: lellis@raine.uwa.edu.au

Company OverviewThe management team has a powerful blend ofinternational experience in biotechnologycommercialisation, the pharmaceutical industry,licensing and capital markets.

Product InformationPotential longer-term applications for BioSilicon™include implant packaging, neural interfacing,biofiltration and diagnostics.

Rockeby Biomed LimitedUnit11, EIR Centre1 Sarich WayBentley 6102WESTERN AUSTRALIATel: +61 8 9470 9444Fax: +61 8 9470 9499Web: www.rockeby.com

Senior Contact: Dr John WarmingtonPosition: Research DirectorEmail: john.warmington@rockeby.com

Company OverviewOur Company was incorporated in Singapore on 9 April2002 as an investment holding company. It currently hastwo wholly-owned subsidiaries, namely Rockeby BiomedLtd (incorporated on 10 March 2000 in Australia) andRockeby Biomed (Singapore) Pte Ltd (incorporated on31 May 2002). We are committed to the discovery,development, marketing and distribution of innovativetechnologies and new bio-pharmaceutical products inorder to enhance peoples’ health and life. In particular,we specialise in the areas of Systemic Candidiasis andThrush.

Rowe Scientific Pty Ltd11 Challenge BoulevardWangara 6065WESTERN AUSTRALIATel: +61 8 9302 1911Fax: +61 8 9302 1905Web: www.rowe.com.au

Senior Contact: Mr Reg RowePosition: Managing DirectorEmail: rowewa@rowe.com.au

Company OverviewRowe Scientific supply quality scientific products,distribute an extensive ranges of instruments, chemicalsand consumables, and undertake analysis and researchfor the mining industry, as well as conducting metallurgyand clinical testing.

Royal Perth HospitalWellington StreetPerth 6000WESTERN AUSTRALIATel: +61 8 9224 2244Fax: +61 8 9224 3511Web: www.rph.wa.gov.au/rph.html

29

Senior Contact: Dr Simon MallalEmail: simon.mallal@health.wa.gov.au

Company OverviewThe Hospital has a close association with the Schoolof Medicine at the University of Western Australia, andwith other state universities involved in the training ofnursing and other health professionals. Teaching andresearch are an integral part of everyday activities atRPH and help to ensure continuing high standards ofcare for our patients. The high standing of RPHresearchers is demonstrated by their significantcontribution to the annals of international scientificliterature each year. Last year, a total of 158 articlesand 114 abstracts were published in refereed medical,nursing and scientific journals. In addition, staffpresented a total of 190 papers at national andinternational professional conferences.

Rumen BiotechSouth StreetMurdoch 6150WESTERN AUSTRALIATel: +61 8 9360 2122Web: wwwscience.murdoch.edu.au/centres/rumen/#

Senior Contact: Prof Keith GreggPosition: DirectorEmail: kgregg@central.murdoch.edu.au

Company OverviewRumen Biotech is dedicated to providing benefits toanimal health and animal production through thegenetic manipulation of gastrointestinal tract bacteria.

Saturn Biotech Ltd8 Dover StreetMt Hawthorn 6016WESTERN AUSTRALIATel: +61 8 9443 8111Fax: +61 8 9443 8199Web: www.saturnbiotech.com.au

Senior Contact: Mr Mark PittsPosition: Director - OperationsEmail: markp@saturnbiotech.com.au

Company OverviewSaturn Biotech (Saturn) had its origins in the need fora partner to take IP developed by research institutionsto the market; and provide an ongoing commercial focusto ensure market needs were a key ingredient duringall phases of the R&D process from selection todevelopment. The aim of the business is, to berecognised as a world leader in biotechnology throughthe use of genomics and proteomics in a highthroughput environment, for the development ofsustainable solutions to agricultural and environmentalproblems and the delivery of smart commercialoutcomes. In late 2001, Saturn was asked to join aconsortium of institutions and state government bodiesto form a ‘Centre for High Throughput AgriculturalGenetic Analysis’ (CHAGA) to be situated at theWestern Australian State Agricultural BiotechnologyCentre (SABC) based at Murdoch University. The

partners in this venture include Murdoch University,Curtin University of Technology, Saturn Biotech Limitedand The Western Australian Department of Agriculture.The aims of this venture are entirely synonymous withthose of Saturn and it will be a driver for IP developmentover the coming years which will ensure that Saturn isat the very forefront of grain testing and certification.

Product InformationSaturn currently provides a number of services forindustry and researchers employing moleculartechniques these fall broadly into two areas Analyticalwork and Diagnostic work.Analytical services -Variety identification - Saturn provides varietyidentification (VID) of grain for plant breeders, growersand marketers. VID is provided using either a uniqueprotein profiling method using a MALDI-TOF massspectrometer or DNA analysis using a variety of currentmethods including micro-satellites, AFLP’s etc. Saturnis also reviewing a number of other technologies, whichcould also deliver a high throughput low cost outcome.Diagnostic services:Saturn provides pathogen testing for breeders andgrowers of seed; farm animals and companion animalsusing DNA analysis employing techniques such asmicro-satellites and AFLP’s. Saturn also offers DNAanalysis using real time PCR techniques (Taqman) andprovides a robust quantitative test. These services areprovided from an accredited PC2 containment facilitywith access to DNA sequencers; a MALDI-TOF massspectrometer; a GeneTAC 3 Microarrayer and arraymodem; proteomics facilities; and a wide range ofequipment required for molecular research.

Solbec Pharmaceuticals LtdLevel 1, 10 Stirling HighwayNedlands 6009WESTERN AUSTRALIATel: +61 8 9386 9422Fax: +61 8 9386 9473Web: www.solbec.com.au

Senior Contact: Mr Stephen CarterPosition: Managing DirectorEmail: info@solbec.com.au

Company OverviewSolbec Pharmaceuticals (formerly Britannia Gold - aWA mining company) is developing a new non toxicanti cancer drug BEC(R). BEC(R) has shown excellentactivity in the treatment of many forms of cancer. Pre-clinical studies carried out by Solbec have shown thatBEC has strong anti-cancer activity against a widerange of cancers with virtually no toxicity to normal cells.In addition to the BEC project, Solbec has also enteredinto a joint development venture with Perth-basedhealthcare company, Lawley Pharmaceuticals toadvance and register a range of steroid hormonereplacement therapy products.

30

Talon Resources55 Collie StreetAlbany 6330WESTERN AUSTRALIATel: +61 8 9481 3922Fax: +61 8 9482 1644Web: www.talonresources.com.au

Senior Contact: Mr Anthony ParryPosition: Chief Executive OfficerEmail: info@talonresources.com.au

Company OverviewA rapidly emerging player in the development ofenvironmental and agricultural solutions using naturalzeolite minerals and specialised knowhow (forecastrevenue $3.2 million this year). Australia’s leadingsupplier of absorbent mineral products for pet litter andindustrial spill clean-up (forecast revenues $9.3 millionthis year).

Telethon Institute for Child Health Research100 Roberts RoadSubiaco 6008WESTERN AUSTRALIATel: +61 8 9489 7777Fax: +61 8 9489 7700Web: www.ichr.uwa.edu.au

Senior Contact: Mr Bruce McHarriePosition: Chief Financial OfficerEmail: brucem@ichr.uwa.edu.au

Company OverviewThe Institute is a centre of excellence dedicated to child,adolescent and family health research in its broadestcontext. It was conceived in 1985 and opened in 1990with Professor Fiona Stanley as the Founding Director.The Institute provides a multidisciplinary researchenvironment that encourages a coordinated collaborativeresearch effort to solve the complexities of childhooddiseases. The Institute is unique in Australia as itcombines the three major disciplines in medical researchto investigate the causes of childhood diseases: basiclaboratory science, clinical science and population-based science.

Product InformationKeys areas of expertise:• Aboriginal child health• Asthma, allergies and respiratory disease• Birth defects• Child and adolescent mental health• Childhood disabilities and death• Infectious diseases• Leukaemia and other cancers

Titan Resources NL24 Outram StreetWest Perth 6005WESTERN AUSTRALIATel: +61 8 9481 6040Fax: +61 8 9481 6035Web: www.titanresources.com.auSenior Contact: Ms Tamsin WilliamsEmail: titan@titanresources.com.au

Company OverviewTitan Resources NL is a mining and mineral explorationcompany based in Western Australia and is listed onthe Australian Stock Exchange (ASX Code: TIR). Thefoundation for Titan’s recent growth came from thesuccessful mining operations at Radio Hill. Followingthe completion of operations at the Radio Hill massivesulphide orebody containing nickel, copper, cobalt andpalladium in September 2002, the company hasaccumulated substantial cash reserves, which haveenabled the progress of it’s innovative Bioheap™bacterial heap leaching process and enhanced thecompany’s ability to carry out an active and excitingprogram of exploration, directed specifically at basemetal deposits available to use for the Bioheap™process.

Product InformationTitan Resources NL has been involved in thedevelopment of a new, innovative process for theextraction of base metals from sulphide ores. Thisprocess is called BioHeap™. BioHeap™ uses aspecialised and proprietary strain of bacteria to oxidisethe sulphide components of mineralised material torender them soluble in a dilute sulphuric acid solution.The bacterial culture breaks the iron and sulphur bondswithin the mineral thereby releasing the associatemetals, copper, nickel, cobalt zinc etc into solution. Thisnatural process is enhanced by the irrigation of a solutionover coarse ore stacked in a heap, as in typical heapleach operations. BioHeap™ has substantialenvironmental benefits in the form of minimal pollution,minimal greenhouse gas emissions and low energyconsumption.

Tri-Med Distributors Pty Ltd1050 Hay StreetSubiaco 6008WESTERN AUSTRALIATel: +61 8 9388 1444Fax: +61 8 9388 1744Web: www.trimed.com.au

Senior Contact: Dr Aruni H.W. MendisPosition: Manager, Scientific & Regulatory AffairsEmail: info@trimed.com.au

Company OverviewTRI-MED has two divisions, Tri-Med International PtyLtd (R&D) and Tri-Med Distributors Pty Ltd (CommercialOperation).TRI-MED is committed to research, development,manufacture and distribution of diagnostic devices andtherapeutics for the health sector.TRI-MED’s primary focus is the stomach ulcer andstomach cancer causing bacterium Helicobacter pylori,which infects approximately three billion peopleworldwide. TRI-MED holds strategic patents ondiagnostic methods relating to H. pylori. TRI-MED is nowinvolved in other areas of diagnostic technology, as wellas the distribution of specialised pharmaceuticalsIn 1998, Tri-Med Specialties Inc. (the United States partof TRI-MED) was acquired by Ballard Medical Products,now a fully owned subsidiary of Kimberley ClarkCorporation. The manufacture of products such asCLOtest was relocated to the USA without change to

31

the manufacturing process, illustrating the world-classbiotechnology and manufacturing capabilities of ourorganisation.TRI-MED maintains mutually beneficial commercialrelationships, including a strategic R&D alliance andlong-term contractual distribution rights with the UnitedStates-based multi-national Kimberley ClarkCorporation.TRI-MED has initiated research programs that build onexisting research strengths in genomics and proteomicsto develop novel diagnostics tests for H. pylori.Additionally, Kimberley Clark Corporation is investing injoint research programs, which have also beensupported by the Western Australia State Government.TRI-MED’s advisors include the US-based Institute forGenomic Research where the H. pylori organism wasfirst sequenced.TRI-MED also has a collaborative patent agreement withthe University of Western Australia.

Product InformationDiagnostics include:• CLOtest® - an in vitro device for the detection of

Helicobacter pylori in gastric mucosal biopsiesduring endoscopy;

• PYtest® - a radiopharmaceutical diagnostic [14C-urea]-breath-test (14C - UBT) for the detection ofHelicobacter pylori in patients;

• Sponsor/Agents in Australia for Ameritek in vitrodiagnostic devices - dBest hCG-urine dip-strips/cassettes, dBest Chlamydia dip-strips & InfectiousDiseases Tests, dBest Drugs of abuse Tests (5 Paneland 10 Panel), dBest H.pylori Antibody TestCassette, dBest H.pylori Urease Antigen TestCassette, & dBest Tumour Marker Tests.

Therapeutic Agents include:• Nitazoxanide (Trade name Cryptaz®) - a broad

spectrum anti-infective for the treatment of refractoryCryptosporidium, Blastocystis, Giardia, Entamoebainfections; Helminth infections; & some Gramnegative, Gram-positive bacterial infections.Nitazoxanide is a TGA-designated Orphan-Drug inAustralia.

• Tri-Med are the exclusive agents appointed byRomark-Laboratories ,Tampa, USA—themanufacturers of Nitazoxanide in Australia. (TradeName in USA: Alinia®; Trade Name in Australia:Cryptaz®. Available in Australia via the TGA’sSpecial Access Scheme).

• Furazolidone: Useful in the treatment of multi-resistant H.pylori. Available in Australia via the TGA’sSpecial Access Scheme.

University of Western Australia, Office ofIndustry and Innovation35 Stirling HighwayCrawley 6009WESTERN AUSTRALIATel: +61 8 9380 3838Web: www.uwa.edu.au

Senior Contact: Dr Andy SierakowskiPosition: DirectorEmail: afs@admin.uwa.edu.au

Company OverviewThe University of Western Australia is recognisedinternationally as an excellent research-intensiveuniversity and is a member of the prestigious ‘Group ofEight’ Australian research-intensive universities. UWAis characterised by a strong research and post-graduateemphasis based on, and closely linked to, a high qualityundergraduate education across the range of disciplinesin the arts, sciences and the major professions includinglaw, medicine, engineering and computer science.The University’s research effort has had a majorcontribution to scholarship and research in medicalscience, the fundamental sciences, social science andthe humanities. UWA attracts more competitive researchfunding (per capita) than any other Australian university,and attracts research staff and graduate students fromall over the world. The University’s reputation forinternationally excellent research has resulted in majorgovernment and industry collaborations. The Universityhosts, or is a core member of, a range of nationalcooperative research centres.UWA has a strong presence in life sciences and hasenjoyed continued success in attracting significantresearch funding.The Office of Industry and Innovation(www.oii.uwa.edu.au) at the UWA is keen to exploreopportunities for collaborative research as well aslicensing and other commercialisation of its discoverieswith interested Biotech Companies.

Product InformationThe university currently holds patents in the followingareas:Alzheimer’s Disease – a diagnostic test based on genetic

risk factorsBreast cancer – identification of a novel target for

therapeutic designNovel Tumor Suppressor Gene – a diagnostic test for

breast, colorectal and prostate cancerLiver disease and liver cancer – a diagnostic index based

on the ratio of tissue specific markersFlavivirus resistance gene – showing broad resistance

to many human flavivirus infectionsAntisense oligonucleotides – a simple method for

selecting active oligonucleotidesAreas where IP is being developed include:Bioluminescence Resonance Energy Transfer (BRET)

– for drug discoveryNovel metal-based cancer therapies – designed to target

cancer cellsCarrier peptide strategies – for the delivery of cancer

therapiesNovel antibiotic targets – and the development of a new

class of antibioticsWound healing treatments and screening for

susceptibility – particularly for venous leg ulcers

University of Western Australia, Department ofAnatomy and Human Biology35 Stirling HighwayNedlands 6009WESTERN AUSTRALIATel: +61 8 9380 3290Fax: +61 8 9380 1051

32

Senior Contact: Ms Maxine CutterPosition: Administration OfficerEmail: adminsec@anhb.uwa.edu.au

University of Western Australia - School ofElectrical, Electronic and ComputerEngineering - Optical and BiomedicalEngineering Laboratory35 Stirling HighwayNedlands 6009WESTERN AUSTRALIATel: +61 8 93807112Fax: +61 8 93801319Web: www.obel.ee.uwa.edu.au

Senior Contact: Professor David SampsonPosition: Head of LaboratoryEmail: dsampson@ee.uwa.edu.au

Company OverviewResearch is conducted into problems in opticalengineering and biomedicine, a field which is oftentermed ‘Biophotonics’. Most of the group’s currentresearch is directed towards opportunities at theinterface between biotechnology and photonics. Thegroup’s focus is on new techniques in biomedicalimaging, optical biopsy and optical monitoring and theirapplication in medicine, and in the life sciences ingeneral. Optical biopsy refers to the provision ofimmediate localised diagnostic information in the humanbody with the goal of aiding or even replacing traditionalexcisional biopsy.OBEL has a disciplinary base in engineering scienceand actively seeks interdisciplinary interaction withmedical and biological scientists and clinicians. Thegroup currently collaborates with a wide range of suchscientists and clinicians in projects funded by nationalcompetitive grants as well as by industry. Projects rangefrom fundamental investigations of new techniques tothe development of instrumentation and it’s applicationin a clinical environment.

Urological Research CentreUniversity of Western Australia35 Stirling HighwayCrawley 6009WESTERN AUSTRALIATel: +61 8 9346 2150Fax: +61 8 9346 4374Web: www.urc.uwa.edu.au

Senior Contact: Mr Stan WisniewkiPosition: DirectorEmail: urc@cyllene.uwa.edu.au

Company OverviewThe Urological Research Centre was established in1993, and is becoming recognised both in Australia andinternationally, as a centre of excellence in research,the further training of urologists from Australia and SouthEast Asia, and the innovative treatment of all forms ofurological disorders in both men and women.

Uropath Pty Ltd & Tissugen Pty Ltd41 Hampton RoadNedlands 6009WESTERN AUSTRALIATel: +61 8 9386 9888Fax: +61 8 9386 9899Web: www.tissugen.com.au

Senior Contact: Dr Kerryn GarrettPosition:Email: kerryn@tissugen.com.au

Company OverviewTherapeutics

Verigen Australia Pty LtdMonash AvenueNedlands 6009WESTERN AUSTRALIATel: +61 8 9293 8273Fax: +61 8 9293 8293

Senior Contact: Mr Paul SandersonEmail: paulanderson@git.com.au

Company OverviewHealthcare

Viaticus Capital Pty LtdLevel 12, BGC Centre28 The EsplanadePerth 6000WESTERN AUSTRALIATel: +61 8 9327 8989Fax: +61 8 9327 8900

Senior Contact: Mr Gavin RezosPosition: Principal and Sole DirectorEmail: gavinrezos@captel.com.auCompany OverviewViaticus Capital Pty Ltd is an Australian private equityarranging and corporate advisory services company,focused on the biotechnology and nanotechnologysectors. Viaticus has arranged funding and sourcedsenior industry executives for each of the followingcompanies:• pSivida Ltd (ASX:PSD)• Australian Cancer Technology Ltd (ASX:ACU)• AI Medics Pty Ltd Boron Molecular Ltd• CollTech Australia Ltd• Australian Development Capital Fund (ASX:ADV)• pSiMedica (UK)• pSiOncology Pte Ltd (Singapore)Viaticus has also assisted a number of companies inobtaining Australian Government grants in thebiotechnology area, including CollTech Australia Ltdand Gene Stream Pty Ltd.

Product InformationViaticus assists in raising early seed and developmentfunding for companies in the biotechnology andnanotechnology fields.Viaticus will assist in sourcing internationally recognisedexecutives and directors from its network of experiencedspecialists in the large pharmaceutical, biotechnologyand counter market fields.

33

Viaticus will assist in the grant funding process, to theextent that Viaticus intends to be an investor in acompany.Viaticus can also assist in general corporate advisoryservices, including business plans, development plans,strategic plans, financial models, corporate structure,merges and acquisitions, licencing and collaborations.

VibraQ CorporationSuite 1, 11 Brodie Hall DriveTechnology ParkBentley 6102WESTERN AUSTRALIATel: +61 8 9472 3392Fax: +61 8 9472 3227Web: www.vibraQ.com

Senior Contact: Mr Barry HobsonPosition: Managing DirectorEmail: bhobson@vibraQ.com

Company OverviewVibraQ is an Australian private company that hasdeveloped a world first planetary electric motor capableof generating dynamic orbital motion. The technologyis suitable and adaptable for all known applications thatrequire any form of non-rotational, eccentric, linear oroscillatory motion and therefore suitable for equipmentrequiring controlled motion for vibrating, mixing, stirring,sieving, screening and suitable for applications in biotechmedical laboratories, medical devices and the generallife-science industry.VibraQ is currently researching and developing thefollowing medical devices for the lifescience industry:• Blood Platelet Agitators• Laboratory Protein Oscillators• Cell Culture Incubators• Cell Fermentor Agitation• Laboratory Bioreactors• Osteoporosis Vibration Therapy• Tissue Health and OedemasVibraQ has a growing IP patent portfolio in the field ofoscillating motion technology and other associatedmedical device applications. Part of the company’sstrategy to commercialise the Intellectual Property is theestablishment of developmental alliances with existingglobal participants in the medical devices industry.

VRI Biomedical LimitedPO Box Z5299Perth 6000WESTERN AUSTRALIATel: +61 8 9321 3655Fax: +61 8 9321 3650Web: www.vribiomedical.com

Senior Contact: Mr John FitzgeraldPosition: Manager IP & Business DevelopmentEmail: John.Fitzgerald@vribiomedical.com

Company OverviewVRI BioMedical (VRI) is a diversified biomedicalcompany focused on the development andcommercialisation of biotherapeutic, diagnostic andvaccine projects that have global markets. These

projects focus on the prediction, prevention andtreatment of diseases in the field of mucosal immunology(the immune system). These include cardiovascular,gastrointestinal, respiratory and gynaecology diseasestates. VRI is an ASX listed company with corporateoffices in Perth, Western Australia. Scientific and clinicaldevelopment activities are based in Sydney andNewcastle, New South Wales with clinical developmentoccurring in several global locations.

Product InformationVRI BioMedical Ltd is developing a range of projectsbased on many of the immune processes describedabove. These projects fall within three developmentplatforms, namely diagnostic tests, biotherapeutics andoral vaccines.

Diagnostic Tests - An enormous wealth of informationregarding the type and progress of diseases can bedetermined by the measurement of various factorsinvolved in the immune response, eg. specific antibodiesor cytokines expressed. VRI diagnostics are based onthis principle and are predictive of a number of differentdiseases and conditions.

Biotherapeutics - Biotherapeutics (also known asprobiotics) are microorganisms fed to a person insufficient quantities to elicit a beneficial response tohealth. VRI is developing a range of products based onthe ability of certain bacteria to boost the host’s immuneresponse to infection and disease and/or preventinvading microorganisms from attaching and growing.Importantly bacteria must be delivered to the smallintestine alive, metabolically active and in sufficientnumbers. VRI has shown that only specific strains ofbacteria will provide these benefits. VRI is developingbiotherapeutic products to prevent and/or treat suchconditions as diarrhoea, irritable bowel syndrome,allergy/asthma, dermatitis and endotoxaemia. TheCompany has already completed a supply agreementwith a large global marketing and distribution partner tosell “PCC™” Lactobacillus fermentum, one of VRI’sexclusive biotherapeutic isolates.

Oral Vaccines - Vaccines are innocuous forms ofinfectious organisms or their toxins that retain the abilityto produce an immune response. The body will thenproduce a vigorous and highly specific response to theantigen should the antigen present again in the future.

WA State Agricultural Biotechnology CentreMurdoch UniversityMurdoch 6150WESTERN AUSTRALIATel: +61 8 9360 2424Fax: +61 8 9360 6303Web: www.sabc.murdoch.edu.au

Senior Contact: Professor Mike JonesPosition: DirectorEmail: mgkjones@central.murdoch.edu.auCompany OverviewThe SABC is a collaborative university Centre for R&Din agricultural and veterinary biotechnology. The SABCis unique in combining university, state government and

34

industry researchers together in one cost-effectivecentre, and operates as a ‘Research Hotel’ model, inwhich different university, government and industryresearcher groups rent common laboratory space andaccess to platform technologies. The SABC supportsincubation and co-location of new ag biotech companiesin WA (eg Grain Biotech Australia, Saturn Biotech andProteomics International) and promotes collaborativeresearch between different groups, as well as having abroad network of local, national and internationallinkages.

Product InformationThe major research focus at the SABC is on molecularactivities that involve or promote primary production ofcommercial livestock, crop plants or microbes, or theirsubsequent processing for added value. Because ofits inclusive nature, the SABC also supports someresearch in biomedical sciences, and environmentalbiotechnology.The SABC provides the most comprehensive set ofequipment and facilities for biotechnology R&D in WA,with full facilities for:• Cell and molecular biology,• Robotics, high throughput agricultural analyses and

diagnostics,• Structural, comparative and functional genomics,• Microarray technologies,• Proteomics and mass spectroscopy.In addition, researchers in the SABC work closely withthe major co-located centre for Bioinformatics in WA,the Centre for Bioinformatics and Biological Computing(CBBC). The SABC plays a major role in advancedtraining in agricultural biotech industry in WA.

Western Australian Biomedical ResearchInstituteGPO Box U1987Perth 6845WESTERN AUSTRALIATel: +61 8 9266 2133Fax: +61 8 9266 7485Web: www.wabri.org.au

Senior Contact: Prof Simon CarrollPosition: DirectorEmail: simon.carroll@wabri.org.au

Company OverviewThe Western Australian Biomedical Research Institute(WABRI) is a cooperative venture between CurtinUniversity of Technology and Murdoch University, inassociation with the Chemistry Centre WA, located inthe State’s capital city of Perth. The Institute carriesout leading-edge research into the molecular basis ofdisease control, targeting diseases such as cancer,diabetes, malaria and other parasitic diseases. WABRIbrings together the expertise of more than 70 scientists,many with well-established international reputations inthe fields of biomedical sciences and pharmacology.

Western Australian Institute for MedicalResearchLevel 6, MRF BuildingRear, 50 Murray StreetPerth 6000WESTERN AUSTRALIATel: +61 8 9224 0333Fax: +61 8 9224 0322Web: www.waimr.uwa.edu.au

Senior Contact: Prof Peter KlinkenPosition: DirectorEmail: ptilbrok@waimr.uwa.edu.au

Company OverviewThe Western Australian Institute for Medical Research(WAIMR) was established in March 1998. The foundingpartners were: The University of Western Australia(UWA) and the Research Foundations at Royal PerthHospital (RPH) and Sir Charles Gairdner Hospital(SCGH), whilst the founding sponsor was WesfarmersLimited. The vision of WAIMR was to create a multi-site Institute, which would enhance the intellectualenvironment in WA and become an international leaderin biomedical research that improved health care inWestern Australia.WAIMR would endeavour to do this by:• Ensuring a high level of collaboration amongst

researchers,• Attracting and retaining leading researchers,• Embracing and pioneering new technologies,• Effectively using resources (intellectual, facilities,

equipment),• Establishing a strong commercial focus,• Evaluating progress,• Supporting talent,• Nurturing future research leaders,• Promoting community awareness and participation.

At this time, there are four Program and Research Areasthat constitute the core research groups of WAIMR:• Cancer/Immunology Program which studies the

mechanisms of cancer, leukaemia, cancer-causingagents, immune response to viruses, cancer andimmunotherapy.

• Cardiovascular/Repiratory Program which studiesthe mechanisms of heart attacks, atherosclerosis,asthma and mesothelioma.

• Endocrinology/Musculoskeletal Program whichstudies the mechanism of hormone action andosteoporosis.

• Neuroscience/Neurotrauma Program which studiesthe genetic cause of mental illness and themechanism of repair following nerve damage.

Our target market would be companies prepared toinvest in early stage biomedical discoveries. In addition,contract research possibilities exist in the four areas ofexpertise.

Product InformationTechnology include: Cell and Molecular Biology; Genecloning; DNA sequencing; Differential gene expressionanalysis; Intracellular signalling; Yeast two hybridanalysis; Yeast three hybrid analysis; Protein expressionanalysis; Protein - protein interaction analysis;

35

Immunofluoresence and Confocal Microscopy; Flowcytometry; Tissue analysis; Immunohistochemistry, In-situ Hybridisation etc); Gene delivery; and MicroArray.Services include: Western Australia Research TissueNetwork – biopsy/sample/DNA collection; LotterywestState MicroArray Facility- MicroArray Analysis andProduction, Library Management, Hybridization andScanning services; Bioluminescence Resonance EnergyTransfer (BRET); and DNA Sequencer.

Women and Infants Research Foundation374 Bagot RoadSubiaco 6008WESTERN AUSTRALIATel: +61 8 9340 1437Fax: +61 8 9340 1642Web: www.wirf.com.au

Senior Contact: Professor John NewnhamPosition: DirectorEmail: jnewnham@obsgyn.uwa.edu.au

Company OverviewThe Women and Infants Research Foundation isWestern Australia’s research organisation dedicated tothe fields of Obstetrics, Gynaecology and NewbornMedicine. It is based in Carson House, an eighty-yearold colonial building adjacent to King Edward MemorialHospital which is the sole tertiary level centre for thestate of Western Australia. The Foundation supportsand promotes clinically-relevant research in the fieldsof prenatal prevention of childhood diseases such ascerebral palsy, the fetal origins of adult disease (includingdiabetes and heart disease), fetal medicine (includingprenatal diagnosis and treatment), prevention of pre-term labour and reducing the dangers of early birth,improvements in newborn care, promotion andevaluation of breastfeeding, prevention of postnataldepression, minimal access surgery in gynaecology, andwomen’s health issues such as menopause andcontraception.

World Waste SolutionsPO Box 351South Fremantle 6162WESTERN AUSTRALIATel: +61 8 9335 1972Fax: +61 8 9335 7862Web: www.geoaustralia.com.au

Senior Contact: Mr Brian MaherPosition: Managing DirectorEmail: tpw@global.net.au

Company OverviewBioenvironmental Product: The manufacture, marketingand selling of Grease and Odour Eliminator (“GOE”) asan enzyme based, non hazardous, biodegradablecleaning product and deodoriser. It is prepared fromnatural ingredients through a fermentation process thatcreates an environmentally friendly cleaner, which alsoeliminates grease and unpleasant odours. GOEcontains naturally occurring bacteria stimulated byenzymes, which as biological catalyst to destroy thehost environment of organic waste.

Product InformationGOE is a Western Australian manufactured product thathas obtained Australian Quarantine Inspection Services(AQIS) classification under Category 1 as a GeneralCleaner Type A for use in export meat establishments.GOE accelerates degradation of waste build up inplumbing waste lines, eliminates ammonia andhydrogen sulphide emanating from humanm and animalfaeces and assists with the destruction of blue greenalgae in sewage settling ponds.

Xcell DiagnosticsLevel 1, 173 Mounts Bay RoadPerth 6000WESTERN AUSTRALIATel: +61 8 9321 2712Fax: +61 8 9485 0602Web: www.xcell.com.au

Senior Contact: Dr Saliba SassinPosition: Chief Executive OfficerEmail: xcell@xcell.com.au

Company OverviewXcell Diagnostics Limited (XEL) is a biomedical devicesgroup listed on the Australian Stock Exchange. TheCompany is focused on the application of biophotonicsfor the diagnosis and management of major diseases.Xcell also develops incentive paediatric respiratorydevices.In February 2003, Xcell acquired the German groupVisiomed AG to secure the exclusive world-wide rightsfor the application of organic vision technology in themedical field. As part of the acquisition, Xcell nowcontrols the “microDERM®” digital dermatoscope, asystem for the diagnosis and documentation ofmelanoma. The Company is developing a number ofother applications including skin cancer screening, 3-Dskin surface analysis and hair analysis.In 2002, Xcell acquired InfaMed Limited and now ownsthe Funhaler®, a proprietary incentive paediatric spacerdevice which is designed to help children suffering fromasthma to take their medication.

36

PROFESSIONAL SERVICE PROVIDERSAmmtec Ltd6 Macadam PlaceBalcatta 6021WESTERN AUSTRALIATel: +61 8 9344 2416Fax: +61 8 9345 4688Web: www.ammtec.com.au

Senior Contact: Mr Rod SmithPosition: Managing DirectorEmail: manager@ammtec.com.au

Company OverviewAMMTEC (Australian Metallurgical & Mineral TestingConsultants) was established in 1979 and has steadilygrown to become one of the largest metallurgical andmineral testing consultancies in the world. TheCompany was listed on the Australian Stock Exchangein 1994. Metallurgical testing consultancies distinguishthemselves from mineral assay laboratories byemploying testwork processes which require far higherresources of skilled staff and facilities. Accordingly,unlike the mineral assay industry, there is only a limitednumber of comprehensive metallurgical facilities worldwide. AMMTEC’s success in this niche market isattributable to a philosophy of creating the highestpossible service levels in terms of providing accurateand timely testwork coupled with extremely high levelsof interpretation and reporting. This has been achievedas a result of creating a core of skilled and experiencedspecialists equipped with an extensive range of testingfacilities.

Product InformationAMMTEC’s services include analysis, bacterialleaching, cyanide detoxication, vanadium, flotation,pressure aid leach, solvent extraction, resin ionexchange, PSI substrates, and services to the gold andiron ore industries.

AtSource Organics Australia Pty LtdPO Box 142Midland 6936WESTERN AUSTRALIATel: +61 8 9255 1401Fax: +61 8 9255 1840Web: www.atsourceorganics.com.au

Senior Contact: Mr John WalkerPosition: FounderEmail: johnwalker@atsourceoganics.com.au

Company OverviewAt Source Organics (ASO Holdings Pty Ltd) is anunlisted company incorporated in Australia tocommercialise technology developed by inventor/researcher John Walker and his associates. Themanagement team is mature with qualified andexperienced individuals who have been selected fortheir ability to offer complementary skills. Expertiseincludes the executive, financial, scientific, logistical,

marketing, and operational areas of business. Otherskills are brought in as needed.Government and industry grants and assistance havesupported the team’s work. Team members havemanaged their own successful businesses in Australiaor have consulted to clients in sustainable industriesand in the fertiliser and composting industry. Othermembers’ relevant experience includes managementover a 10-year period of a 35-employee, $A10 millionper annum waste management subsidiary of aninternational corporation, as well as internationalbusiness development and marketing in the UnitedKingdom, Europe and the USA.

Product InformationThe TumbleTainer™ - the TumbleTainer is a large, fully-automated, rotating vessel, processing at least 2,000tonnes of waste per annum when assuming a 7-dayretention period. Thermophilic composting isaccelerated and odours are minimised by creating anenvironment that controls moisture, aeration, andtemperature. Climatic conditions cease to be a limitingfactor. Carbon dioxide and heat created in the processcan be recycled for stimulating greenhouse crop growth.Each ASO composting unit will accrue greenhouse gascredits equivalent to 5,500 tonnes CO2 per annum. TheTumbleTainer quickly converts a waste problem intoimmediate, high value end-products, as marketablecompost and/or feedstock for the VermiTainer.The VermiTainer™ - each VermiTainer is 12 metres longand holds eight 3-metre worm units. Worms are fedprocessed compost from the TumbleTainer.Temperature and moisture are controlled, optimisingworm efficiencies and cast production, which canexceed 250 kg per day. VermiTainers can be stackedup to 10 high, to minimise footprint.

Biomedical Investments LtdEagle Jetty20 Mews RoadFremantle 6160WESTERN AUSTRALIATel: +61 8 9335 9921Fax: +61 8 9335 9941Web: www.nelsoncapital.com.au

Senior Contact: Mr Justin BirchmorePosition: DirectorEmail: birchmore@nelsoncapital.com.au

Company OverviewBiomedical Investments seeks to assist in thecommercialisation of biomedical R&D product throughthe contribution of its corporate skills, global contactsand access to capital. Biomedical Investments is alsoactively involved in the identification of suitable licensingpartners in Australia for foreign companies and hasdedicated recent efforts to the replication of successfuloverseas business models on a shared equity basis tofacilitate the international expansion ambitions of itsclients.

37

Biotechnology International Advisory Services43 Sulman AvenueSalter Point 6152WESTERN AUSTRALIATel: +61 8 9450 5298Fax: +61 8 9313 4256Web: www.bias.net.au

Senior Contact: Prof Pat CarnegiePosition: Chief Executive OfficerEmail: carnegie@bias.net.au

Company OverviewProvides technical advice in biotechnology tocompanies and investors. Provides projectmanagement for research in agricultural and medicalbiotechnology.

Centre for Medical and Surgical Skills (CTEC)University of Western Australia35 Stirling HighwayNedlands 6009WESTERN AUSTRALIATel: +61 8 9380 8551Web: www.ctec.uwa.edu.au

Senior Contact: Mark GummerPosition: Chief Executive OfficerEmail: mgummer@ctec.uwa.edu.au

Company OverviewA unique purpose built, state of the art medicaltechnology facility of world standing. CTEC provides avariety of hands-on practical training courses for medicaland surgical professionals across all disciplines and atall career levels. The ambitious project began with avision to contribute to better medical and surgical skillstraining and ultimately better health in Western Australiaand beyond. The shared vision, support and commitmentof the CTEC partners has created the most technicallyadvanced medical and surgical skills training centre inthe Southern Hemisphere.

Churchill Capital Services Pty LtdLevel 35, Exchange Plaza2 The EsplanadePerth 6000WESTERN AUSTRALIATel: +61 8 9278 1890Fax: +61 8 9421 1113Web: www.churchillcapital.com.au

Senior Contact: Mr Patrick O’ConnorPosition: Managing DirectorEmail: patrick.oconnor@churchillcapital.com.au

Company OverviewChurchill Capital is a private, independent financialservices and management consulting group. Originallyestablished in 1987 to meet treasury needs in theresources sector, we have evolved into a boutiqueinvestment banking and consulting group, deliveringhigh-value, focused solutions in disciplines includingcorporate advisory, management consultancy, propertyand treasury services.

Product Information

CORPORATE ADVISORYOur corporate advisory group, predominantly operatesin the growth technology, life sciences, environmentalsolutions and resource sectors.With access to private capital as well as institutionalfunds, Churchill Capital harnesses powerful and proveninvestment models to provide financial solutions to clientcompanies.Corporate advisory services include: undertaking duediligence research and providing corporate investmentadvice; providing strategic advisory services in the areasof private and public equity raisings and project andstructured financing; sourcing or providing our own“seed” capital; providing financial, strategic andcorporate advice from incorporation to “post-IPO”organisation; developing business plans integratingintellectual property management, product development,regulatory licensing, corporate and financial strategies;managing all marketing and communications activities,and coordinating and assisting in all aspects of InitialPublic Offering on Australian or overseas markets;advising on ASX listing rules, Corporations Act and otherregulatory requirements; advising on corporatecommunications strategy including investor relations;identifying Australian investment opportunities; andadvising on mergers and acquisitions.

MANAGEMENT CONSULTINGWe seek to be different by offering pragmatic andforthright solutions to client issues.Our recommendations will be based on sound analysisand proven experience and we are committed to therealisation of benefits for clients.We will engage clients’ managers and staff in workingwith us, to ensure benefit sustainability and futureenhancement.We seek to understand emerging issues and trends andinnovative solutions for our clients.Management consulting services include: undertakingbusiness and operational reviews; developing strategicand operational plans; assessing scope and achievableperformance improvement; designing and implementingorganisational change projects; managing functions ororganisations, undergoing major change; monitoring andassessing realisation of targeted benefits; andestablishing ongoing performance measurement andreview processes.

TREASURYOur treasury capabilities include: currency; commodity;and equity markets.

Clayton UtzLevel 35, Bank West Tower108 St George’s TerracePerth 6000WESTERN AUSTRALIATel: +61 8 94268000Fax: +61 8 9481 3095Web: www.claytonutz.comSenior Contact: Mr Paul FitzpatrickPosition: PartnerEmail: dcox@claytonutz.com

38

Company OverviewClayton Utz is a national first tier law firm that has beenconsistently rated by premier directories as Australia’sleading firm in the areas of life sciences and productliability and has strong capabilities to assist companiesdeveloping and implementing emergingbiotechnologies.In Perth, Clayton Utz distinguishes itself from itscompetitors by the number of lawyers whose expertisein the legal disciplines is complemented by high leveltraining in the sciences, and in particular, inbiotechnology. Clayton Utz offers a comprehensiverange of services to our clients on all aspects ofcommercial & corporate law and dispute resolution.Clayton Utz also specialises in providing creative andinnovative solutions to the challenges which arise inbusiness.

Product InformationOur Corporate specialists:With one of Australia’s largest life science practicegroups, Clayton Utz provides a comprehensive andintegrated suite of services capable of tackling thebusiness needs of the biotech/life sciences industry. Ourcoordinated, multidisciplinary approach means we canhandle all your legal and commercial needs - fromcompany formation to commercial success.

Our Intellectual Property:Experts regularly work on projects within Australia andoverseas. We provide a comprehensive package ofservices including project development, regulatorycompliance, intellectual property audits, patent office &court proceedings and appeals. This translates intobetter value for our clients, every time we work with them.

Our Product Liability:Specialists conduct product liability audits, advise on allaspects of regulation, and represent our clients attribunal proceedings and appeals. We have the skills,expertise and experience to advise clients on the threatsand opportunities which arise under Australia’s productliability laws. By adopting pre-emptive strategiesdeveloped by us, our clients reduce their exposure toproduct liability claims.Whether your business involves biotechnology, medicaldevices, pharmaceuticals or you are part of a venturecapital group, research institute or health serviceprovider, Clayton Utz can help you achieve your businessgoals including: patents and IP generally; thedevelopment of strategic alliances; venture capitaltransactions; the development of policies andprocedures for research centres; negotiating contractsassociated with R&D grants and projects; mergers andacquisitions; taxation issues; new productcommercialisation and licensing; contract manufacturingagreements; registration and listing of therapeutic goods;consumer protection, advertising and labelling; privacylaws; compliance with legislation and policy; IT; productliability; insurance; competition law; environmental lawcompliance; and industrial relations.

Corrs Chambers WestgarthCommonwealth Bank Building

150 St Georges TerracePERTH 6000WESTERN AUSTRALIATel: +61 8 9460 1600Fax: +61 8 9322 6953Web: www.corrs.com.au

Senior Contact: Mr Rob ListerPosition: PartnerEmail: Rob_Lister@corrs.com.au

Company OverviewCorrs Chamber Westgarth is one of Australia’s leadinglegal advisors to corporate, commercial andgovernment clients. We provide a comprehensiverange of legal services and focus on developingeffective business solutions with our clients.

Product InformationCorrs provides commercially relevant legal advice andassistance to biotechnology companies from idea toIPO and beyond. Corrs assists in the commercialisationprocess that is inevitably required to sustain researchand development organisations. Our experienceincludes acting for government departments, researchand academic institutions, start-up companies, small-medium enterprises and multinationals.

Doug McGhie and Associates23 Killamarsh PlaceCarine 6020WESTERN AUSTRALIATel: +61 8 9447 0515Fax: +61 8 9447 2817

Senior Contact: Dr Doug McGhiePosition: PrincipalEmail: dmcghie@multiline.com.au

Company OverviewDoug McGhie & Associates provides business andconsulting services to organisations in the scientific,agricultural, biotechnology and health industries. Wespecialise in planning and strategy for developingscientific centres, along with developing business casesfor winning funding applications.We provide services for all Western Australianuniversities and associated industry partners, workingin the above fields.Successful research centres have been developed inthe areas of Applied Organic Geochemistry, NaturalResource Management, Mass Spectrometry,Sustainable Mine Lakes, Radiochemistry, Soil Healthand Teletesting. Support has been provided in the fieldsof biodiversity, soil enhancement, medical engineering,animal research and many more. Work is ongoing insome of these fields as well as photonics, medicalimaging, biodiversity and others.DR Doug McGhie has the qualifications: B Sc (Agric)Hons, Ph D, MBA

Product Information

39

We provide professional business and strategic planningassistance for developing scientific research centres andfor winning applications for funds for scientific researchand/or development.

Ernst & YoungCentral Park152 St Georges TerracePERTH 6000WESTERN AUSTRALIATel: +61 8 9429 2186Fax: +61 8 9429 2235Web: http://www.ey.com.au

Senior Contact: Mr Peter FergusonPosition: Senior Manager, Innovation & TechnologyGroupEmail: peter.ferguson@ernstyoung.com.au

Company OverviewErnst & Young is a leader in the provision of professionalservices in Australia and around the world. As part ofthe global Ernst & Young network - with more than100,000 people in some 130 countries - our vision is tocontribute most to the success of our people and clientsby creating value and confidence.

Product InformationErnst & Young offers a broad array of services to helpbusinesses capitalise on opportunities for growth,improve financial performance and manage risk. InAustralia, our core service lines are Assurance andAdvisory Business Services, Tax, Corporate Finance andLaw.Ernst & Young is recognised as a leader in Biotechnologyand has for the past 15 years produced reports on theindustry in the U.S.A and more recently in numerousother countries. In 2002 the increasingly cross borderfocus of the industry resulted in the first globalBiotechnology report.

Foundation Capital LtdLevel 12, 225 St Georges TerracePerth 6000WESTERN AUSTRALIATel: +61 8 9322 2360Fax: +61 8 9322 1148Web: www.foundationcap.com.au

Senior Contact: Dr Robert NewmanPosition: Investment DirectorEmail: first@foundationcap.com.au

Company OverviewVenture capital investor:Foundation Capital is one of Australia’s leading venturecapital investors. Based in Perth, Western Australia,Foundation has two key objectives:• to invest long term equity capital in private

companies with strong growth prospects andenterprising management,

• to add value by actively partnering withentrepreneurs to build stronger, more profitablecompanies.

Foundation Capital has been awarded WA’s firstInnovation Investment Fund license by the FederalGovernment. As a result, $35.68 million is available toinvest specifically in early stage investments.Today, Foundation Capital has $113.8 million undermanagement across three funds and is activelywidening its investment scope outside WesternAustralia. Foundation Capital invests between $1 millionand $10 million in opportunities from early stage to pre-IPO.

Product InformationFoundation Capital offers assistance to its investeesthrough:Funding - funding for unlisted companies; 3-5 yearinvestment horizon; investments from $1m to $10m; andfollow on investments for growing companiesManagement Expertise - general business andcommercial experience; strong financial management,analysis and structuring expertise; strategic andoperational input at board and management level; andchallenges to existing thinking.Commitment but not control - a commitment to growthand maximising value; Foundation usually acquires astake of 15% to 30%; we don’t want a controlling positionin the business; and partnering approach is fundamental.Contribution to Growth - management of organisationgrowth and change; assistance with negotiation ofstrategic alliances and locating joint venture partners;access to Australian and international capital marketsand financial institutions; and IPO experience.Areas of InvestmentFoundation Capital’s investment criteria qualifiescompanies that: are Australian based; show potentialfor high growth - through expansion interstate oroverseas; have enterprising management with provenexperience; and have a market niche and/or asustainable competitive advantage.Our due diligence and assessment process is rigorousand requires that the company has; a business plan,financials, projections and identified markets.Foundation’s objective is to create a balanced portfolioof investments across a range of industries including:information and communication technologies; industrialmanufacturing; marine industries; industrial chemicalsand other specialist manufacturing including value addedprocessing to the resources sector; and medical/healthproducts and biotechnology.Foundation Capital also represents Starfish’s pre-seedfund in Western Australia. The Starfish Pre-Seed Fundis a broadly focussed technology Fund. The Fund willinvest into Life Science, Information Technology andCommunications and other technologies from whichglobally competitive can be grown from an Australianbase.

Griffith HackLevel 6256 Adelaide TerracePERTH 6000WESTERN AUSTRALIATel: +61 8 9221 3779Fax: +61 8 9221 4196Web: www.griffithhack.com.auSenior Contact: Dr Stuart Boyer

40

Position: PrincipalEmail: stuart.boyer@griffithhack.com.au

Company OverviewGriffith Hack is Australia’s first truly integratedtechnology and intellectual property firm and offers aunique range of services including protecting,managing, exploiting and defending intellectual propertysuch as patents, trade marks and copyright. GriffithHack employs over 200 people nationally includingmore than 75 professionals and 140 support staff. Withoffices in Sydney, Melbourne, Brisbane and Perth theyare able to provide effective dispute resolution andcommercial advice. As a national firm Griffith Hack isideally positioned to service the local and interstateneeds of Perth clients.

Product InformationGriffith Hack is a multi-disciplinary technology firmcomprising: Griffith Hack Patent and Trade MarkAttorneys; Griffith Hack Lawyers; and IntellectualProperty Management Pty Limited.Griffith Hack Patent and Trade Mark Attorneys isAustralia’s largest national patent and trade mark firm.We deal in all aspects of patents, trade marks andregistered designs, from registration through toprosecution and enforcement. Our firm has expertisein all types of technology including animal and plantbiotechnology and pharmaceutical chemistry.Griffith Hack Lawyers is fully integrated with Griffith Hackpatent and trade mark attorneys and practises in anumber of specialised areas to advise clients on allaspects of technology, intellectual property andenforcement, including litigation. A fast-growing andcompetitive arm of Griffith Hack, the law firm wasestablished in 1992 as an affiliate of the Patent & TradeMark firm, and shares its offices in Sydney andMelbourne.Intellectual Property Management Pty Limited providesoutsourced services for the management of patent andtrade mark portfolios for both the government andprivate sector, including CSIRO.Through Griffith Hack’s involvement in intellectualproperty worldwide for more than 100 years, GriffithHack enjoys a network of international agents unrivalledby even the largest law firms. We service local andinternational clients doing business within Australia andoverseas. We provide a comprehensive range ofservices to major Australian and internationalcompanies in both public and private enterprise in abroad range of industries including manufacturing,entertainment, media and communications,pharmaceutical, information technology, engineering,construction, mining, textiles and telecommunications.

Innovation Research AustraliaSuite 18123A Colin StreetWest Perth 6005WESTERN AUSTRALIATel: +61 8 9226 4466Fax: +61 8 9226 4455

Senior Contact: Mr Peter EvansPosition: PrincipalEmail: peter@innovation.com.au

Company OverviewInnovation is the process that translates knowledge intoeconomic growth. Innovation is much more thaninvention or R&D. It encompasses all activitiesencouraging the commercialisation and utilisation ofnew technologies — scientif ic, technological,organisational, financial and business. It is now widelyaccepted that innovation is the key to future prosperity.Dr Robin Batterham, The Chance to Change, FinalReport by the Chief Scientist, November 2000.Innovation Research Australia is a small, but highlycapable professional company that has the strategicaim of adding value to client operations through theprovision of high quality, professional and value formoney innovation consultancy services.The company views clients as partners and understandsthat one size does not fit all. Innovation ResearchAustralia has the depth of experience to ensureindividual client needs are understood and exhibits aflexible, client focused approach. The company stronglybelieves in building long term strategic relationshipswith clients, which is exemplified by the fact that mostof the company’s work is repeat business. Unlike largeconsulting companies, the Principal personallysupervises every project undertaken, includingfacilitation and client liaison.Innovation Research Australia has completedsignificant projects in both the private and publicsectors, and counts major clients as The University ofWestern Australia, Curtin University of Technology andMurdoch University. The company has beensignificantly involved in the WA Government Centresof Excellence program, having completed strategicbusiness plans for approximately one-third of all suchcentres in the State.

Product InformationThe company’s capabilities include the provision of thefollowing services in the attraction of funding forparticular proposals or for organisations, as well asorganisational innovation, management andgovernance.Funding Attraction: Innovation Research Australia is wellplaced to assist organisations to attract funding from arange of sources including government, private sectorand venture capital funds. The services the companyprovides include:• Grant and Project Applications, Submissions and

Proposals - comprehensive assistance with thepreparation of all types of grant applications andproposals. The company is experienced in anumber of major funding programs including:AusIndustry START and other Department ofIndustry, Science and Resources based programssuch as COMET; Department of Education, Scienceand Training programs including the CooperativeResearch Centres (CRC) Program; AustralianResearch Council (ARC) programs; WAGovernment Centres of Excellence; and AusAidprograms.

• Business Planning - complete assistance with thedevelopment of business plans to attract funding,either as stand alone documents or as part of a grantapplication. The company is highly experienced inthe preparation of business plans for the WAGovernment Centres of Excellence program.

41

• Feasibility Studies - preparation of feasibility studiesto attract funding from external sources, or as partof internal proposal development.

• The Research and Development Tax Concession -the principal of Innovation Research Australia waspreviously appointed as one of only 12 ContractTechnical Assessors in Australia for the R&D TaxConcession. This significant appointment by theIndustry Research and Development Board involvedthe provision of assessments on claimant projectsto the Board. Thus, the company is well placed toprovide assistance in all aspects of the TaxConcession.

• Government Funding and Liaison - experienced inidentifying the most appropriate sources ofgovernment funding for proposals and provision ofa range of assistance including liaison,representation and negotiation with fundingagencies.

Management, Governance & Innovation: InnovationResearch Australia provides a range of services toenhance organisational innovation, management,performance and governance. These services include:• Strategic Planning - comprehensive assistance in

the development of strategic plans for both publicand private sector organisations, including fullfacilitation of the planning process, production ofplanning documents and liaison with stakeholders.

• Scenario Planning - complete assistance withscenario planning either as part of a business,strategic, or risk management plan, or as a standalone activity.

• Strategic Risk Management - provision of strategicrisk management services including assessment,planning and implementation. All risk managementservices are consistent with Australian Standards.

• Project Management - experienced in all aspects ofproject management encompassing planning,facilitation and implementation across bothproducts/systems and intellectual/knowledge-basedprojects.

• Policy Formulation, Planning and Evaluation -provision of full policy formulation, planning andevaluation services for business, government oracademic organisations. Evaluation servicesinclude organisational, project and programevaluation.

• Facilitation - the principal of Innovation ResearchAustralia is a widely experienced facilitator havingfulfilled this role for both public and private sectorclients.

• nnovation, Commercialisation and ProcessImprovement - advice and assistance with processimprovement in a company, academic institution,or government organisation including developmentof strategies, operations management,commercialisation of research, and facilitation ofacademic, government and industry interaction.

• Analytical Problem Solving and Provision ofIntelligence - delivery of independent assessments,based on targeted research and analysis into areasof organisational interest or concern. Provision ofa full knowledge service from collection of data toprovision of analytical reports, including theapplication of analytical techniques to problems.Experienced in international strategic, industry andeconomic analysis.

• Professional and Technical Writing - InnovationResearch Australia has extensive experience inprofessional and technical writing. The companycan provide clear, concise, accurate andpersuasive writing for results, wherever high qualitycomposition is required. This includes conveyingtechnical information to the non-technicalaudience, and the development of annual andtechnical reports, organisation profiles/marketingdocuments, proposals, submissions or otherdocuments.

Lakefield Oretest Pty Ltd12 Aitken WayKewdale 6105WESTERN AUSTRALIATel: +61 8 9353 3326Fax: +61 8 9353 1028Web: www.oretest.com.au

Senior Contact: Mr John AngovePosition: General ManagerEmail: johna@oretest.com.au

Company OverviewLakefield Oretest provides one of Australia’s mostadvanced metallurgical testwork and research facilities,responding to the diverse and challenging issues inthe mineral processing industry.

Product InformationThe laboratory is dedicated to providing high qualitymetallurgical testing across the broad spectrum of themineral industry. This includes testing ores andconcentrates of gold ores, base metals, iron ore, mineralsands, diamond ores as well as development ofenvironmental testing programs, all of which are cateredfor at the one amenity.

Lord and Company4 Douro PlaceWest Perth 6005WESTERN AUSTRALIATel: +61 8 9481 1309Fax: +61 8 9481 4705Web: www.lordco.com.au

Senior Contact: Kelvin LordPosition: PrincipalEmail: lordco@lordco.com.au

Company OverviewPatent and Trade Marks Attorneys. Our professionalteam has a background of over 30 years Australianand International experience in the preparation, filingand prosecution of Patent, Trade Mark and DesignApplications. Our staff has expertise in a wide range ofdisciplines, including biotechnology, chemistry, IT andbiological sciences. Our professional staff remains atthe forefront of developments in technology viasubscriptions to technical journals and participation inprofessional conferences and seminars. Our clientscome from many sectors and span many industries andtechnologies. They include individual inventors, small/medium businesses and multinational companies.

42

Product InformationLord and Co. offer expertise and advise in all areas ofIntellectual Property. These services include: advice onhow best to protect your innovation/idea; preparation,filing and prosecution of patent, trade mark and designapplications, locally and internationally; conduct patent,trade mark and designs searches; professional opinionson IP issues such as infringement and patent validity;oppositions; watching services to monitor yourcompetitors IP; confidentiality agreements; IPawareness/education programs and presentations;strategic IP planning and portfolio management; duediligence reports; and many more related services. Ourstaff has research experience in the areas of chemistry,biochemistry and molecular biology and furtherexperience in the areas of IT, engineering andcommunications.

Marketing Edge Agricultural ServicesCnr Bath & Butcher StreetsBruce RockWESTERN AUSTRALIATel: +61 8 9061 1124Fax: +61 8 9061 1764

Senior Contact: Mr Glenn McTaggartEmail: markedge@comswest.net.au

Company OverviewAgritechnology services

Mosaic Reputation Management97 Barker RoadSubiaco 6008WESTERN AUSTRALIATel: +61 8 9381 4494Fax: +61 8 9381 4494Web: www.mosaicrm.com.au

Senior Contact: Dr David MichiePosition: PrincipalEmail: david@mosaicrm.com.au

Company OverviewMosaic Reputation Management is a full service, virtualcommunications agency with a passion forbiotechnology.Established by a group of communications professionalwhose capabilities have been developed throughexposure to mainstream global markets. Mosaiccombines the features of a full service agency with allthe benefits of the virtual business model. In this way,our biotech clients access an outstanding skill set atcompetitive rates.Our service offering encompasses core corporate andfinancial communications activities from upstreamstrategic counsel to the implementation of investorrelations programs, website development and graphicdesign.From our network of Perth based facilities, we service anational client list and work with international affiliatesrepresented in every major world city.

Product InformationMosaic Reputation Management provides the full rangeof communications tools to help biotech companiesarticulate the benefits of their science to investors,potential partners and other stakeholders.

The Oil Mallee Company of Australia LtdPO Box 1050Fremantle 6959WESTERN AUSTRALIATel: +61 8 93198100Fax: +61 8 93198300Web: www.oilmallee.com.au

Senior Contact: Mr Tym DyncansonPosition: ManagerEmail: info@oilmallee.com.au

Company OverviewThe Oil Mallee Company of Australia was establishedin 1997 as the commercial arm of the Oil MalleeAssociation of Western Australia to facilitate thedevelopment of a sustainable mallee based industryfor the WA wheatbelt, through the attraction of largerscale private investment. It currently employs sevenpeople directly, whilst utilising the services of anadditional seven regional based contractors to carryout field work, assist in marketing and providinglocalised technical expertise within their owncommunities.

Product InformationThe Oil Mallee Company of Australia seeks to undertakeand oversee the establishment of a mallee resource ona large scale which will contribute to the development ofan ongoing and sustainable mallee based industry.Products derived from mallees include oil, activatedcarbon, carbon sinks, carbon credits and renewableenergy. As part of this broad objective is the ability formallees to contribute to assisting in the rehabilitationand remediation of salinity through lowering groundwatertables, as well as general environmental benefits suchas windbreaks, soil stabilisation and general floraldiversity.The Oil Mallee Company is able to carry out all aspectsof project management on behalf of private clients, bothlarge and small, including site selection, plantingestablishment, ongoing management through tomarketing of products derived. OMC participates in arange of research projects in cooperation withuniversities and government agencies.A primary role of the OMC is to coordinate the sales ofhigh oil yielding varieties of mallees to farmers and toassist them in ensuring they are ware of the land types,configurations and techniques required in order toachieve optimal growth rates. Integration of mallees intoexisting agricultural systems makes mallees a morecompatible form of tree planting than other tree typesyielding higher value products.

43

Pricewaterhouse CoopersLevel 19, QV1250 St Georges TerracePerth 6000WESTERN AUSTRALIATel: +61 8 9238 3000Fax: +61 8 9238 3388Web: www.pwc.com

Senior Contact: Mr Ross ThorpePosition: PartnerEmail: ross.thorpe@au.pcwglobal.com

Company OverviewPricewaterhouseCoopers (www.pwcglobal.com) is theworld’s largest professional services organisation.Drawing on the knowledge and skills of more than125,000 people in 142 countries, we build relationshipsby providing services based on quality and integrity.We provide our core services of assurance, businessadvisory, corporate finance and taxation across broadindustry sectors in Perth. To help us focus on a varietyof market sectors we have organised the industry sectorsinto four key business units: Resources, Services andGovernment; Consumer and Industrial Products;Financial Services; and Technology, Information,Communication and Entertainment.

Product InformationPricewatehouseCoopers services include: R&DConcession; R&D Planning; Grant applicationpreparation and review; Corporate advice on R&Dstructures (Income tax and GST implications); Reviewof R&D contact arrangements; Review of licensing andIP transfer arrangements; and Review of Internal IPposition.

Symbion LtdLevel 36, Exchange Plaza2 The EsplanadePerth 6000WESTERN AUSTRALIATel: +61 8 9281 8111Fax: +61 8 9218 8100

Senior Contact: Dr Eric TanPosition: Chief Executive OfficerEmail: admin@symbion.com.au

Company OverviewSymbion is an aggregator and developer of Australianbiotechnology. It has offices in Perth and Sydney andis resourced by scientists and financiers provided byMedical Corporation Australasia Limited and ABNAMRO Australia Limited. If has a number of strategicinvestors and intends to grow by adding value to worldclass technologies. It currently has a group of assetsin the fields of diagnostics, monoclonal therapy andnutraceuticals.

TechStart Australia Pty LtdLevel 3, 220 St Georges TerracePerth 6000WESTERN AUSTRALIATel: +61 8 9480 1188Fax: +61 8 9480 1199Web: www.techstart.com.au

Senior Contact: Mr Conrad CrisafulliPosition: Managing DirectorEmail: marcus.christian@techstart.com.au

Company OverviewTechStart Australia operates in the early stage of thecommercialisation pathway, providing the link betweenproven concepts and commercially successfulbusinesses. TechStart works with these enterprises tobuild and develop business fundamentals allowing thetechnologist to remain focussed on technical outcomes.TechStart Australia has evolved from its original role asa technology transfer vehicle for Western Australia’sleading universities; Curtin, UWA, ECU and Murdoch.Privatised in 1998, and backed by one of Australia’sleading industrialists, Mr Harold Clough, TechStart hasbuilt on its close association with technology providersto build well-developed industry networks.Through equity partnering with the owners of thetechnology our interests are aligned with the success ofthe project. Each technology receives additional value-add through interaction with TechStart’s sophisticatednetwork of technical and commercial contacts, andbenefits from our intimate involvement with innovationacross a broad range of industries.

Product InformationTechStart offers technological and commercialassessments; market research and analysis; in-depthbusiness planning and strategy development; and capitalraising, including grant assistance. TechStart also offershands-on business development and management,customer validation, alliance partnering and ongoingmonitoring and strategic input.TechStart has successfully placed a number oftechnologies with listed companies such as MeditechResearch Ltd, QPSX Communications Ltd and ImugeneLtd. Despite a depressed venture capital market,TechStart successfully secured funding to launch start-up businesses based on technologies arising fromCSIRO, Curtin University and the University of WesternAustralia. Two of these companies were successful inobtaining coveted Biotechnology Innovation Fund grantsof $250,000 in 2002. All of TechStart’s investees arefirmly focussed on provided technology-based productsand solutions for global markets.TechStart’s success can be attributed to their stringentselection criteria that are applied to new projects withongoing assessment at critical points in the project’sdevelopment. The Company prides itself on its ability towork closely with the developers of technology to identifyrisks and develop strategic solutions, based on solidresearch and proven experience.

44

Tessitura Pty Ltd25 Second AvenueKensington 6151WESTERN AUSTRALIATel: +61 8 0409 050 519Fax: +61 8 9368 1219Web: www.tessitura.com.au

Senior Contact: Dr James WilliamsPosition: DirectorEmail: james@tessitura.com.au

Company OverviewTessitura Pty Ltd was founded to providecommercialisation management services to start-up andearly stage companies in the biotechnology and medicaldevice sector. Tessitura has direct experience instructuring, financing and management of start-upcompanies. Tessitura consultants combine leadershipin scientific research and development projects withinvestment banking expertise and hands-onmanagement experience. Directors have published inleading international scientific peer reviewed journalsand are named on a range of scientific and businessprocess patent applications. Depending on theassignment, Tessitura will use its own internal team orutilise its network of associates to form the right teamfor the task.Tessitura’s clients include listed and private companiesand academic research organisations.

Product InformationTessitura provides a range of services including strategicbusiness planning, marketing and competitor analysis,valuations, capital raising, regulatory and quality systemplanning and implementation, process validation,intellectual property management, and corporatestructuring.

Venture Capital Corporation International PtyLtdEvandale House80 Evandale StreetFloreat 6014WESTERN AUSTRALIATel: +61 8 9383 7577Fax: +61 8 9387 6077Web: www.venturecapitalcorp.com

Senior Contact: Mr Sciona BrownePosition: Executive DirectorEmail: browne@evandale.com.au

Company OverviewVenture Capital Corporation International Pty Ltd wasincorporated in 1983 and for many years operated as acorporate and marketing consultancy, developing andimplementing marketing concepts and programs inAustralia and Internationally. It now operates as seedand early stage subsidiary of the boutique venture capitalfirm The Evandale House Group.

Wray & AssociatesLevel 4, The Quadrant1 William StreetPerth 6000WESTERN AUSTRALIATel: +61 8 9216 5100Fax: +61 8 9216 5199Web: www.wray.com.au

Senior Contact: Mr Gary CoxPosition: PartnerEmail: garyc@wray.com.au

Company OverviewWray & Associates is Western Australia’s mostrespected and oldest firm of Patent and Trade MarksAttorneys. Established in 1920, Wray & Associates hasgrown to become the largest Patent and Trade MarksAttorney firm based in Western Australia.Wray & Associates offers a wide range of technicalexpertise embracing Mechanical Engineering,Chemistry, Biotechnology, Pharmacology, Physics,Electronics and Computing.Wray & Associates has a well earned reputation forexcellence, expertise and quality service, which cansafeguard your intellectual property in a competitive andchallenging global market.

Product InformationIntellectual Property protection: Patent, Trade Mark,Design & Plant Breeders Rights Applications - National& International; Searching services; Watching services;Licensing advice; Renewal services.

45

INDUSTRY ASSOCIATIONS AND INTEREST GROUPS

AusBiotech - Western Australia (WA) BranchLevel 1, Building 400Curtin UniversityBentley 6102WESTERN AUSTRALIATel: +61 8 9266 4822Fax: +61 8 9266 7485Web: www.ausbiotech.org/wa

Senior Contact: Ms Erica JagoPosition: Executive OfficerEmail: e.jago@curtin.edu.au

Company OverviewAusBiotech, formerly the Australian BiotechnologyAssociation, is the national body of companies andindividuals dedicated to the development and prosperityof the Australian biotechnology industry. It is the peakbody for the Australian Biotechnology industry, andprovides a ‘platform’ that brings together all the relevantplayers involved in the Australian biosciencescommunity.AusBiotech’s mission is to encourage and facilitate thecommercialisation of Australian biotechnology in thedomestic and international marketplace.The Western Australian Branch of AusBiotech wasestablished in 2001 with an office located at CurtinUniversity. The key objective of the Branch is:“To foster development of the WA BiotechnologyIndustry, by increasing awareness of biotechnology inthe State, representing and advancing the interest ofWA members of AusBiotech in accordance with theobjectives of the national organisation.

Australasian Association of ClinicalBiochemists6/1 Alvin StreetMt Lawley 6050WESTERN AUSTRALIATel: +61 8 9370 4409Fax: +61 8 9370 5224Web: www.aacb.asn.au

Senior Contact: Mr Tony PriorPosition: Executive OfficerEmail: tony@aacb.asn.au

Company OverviewTo advance the study and practice of clinicalbiochemistry.

Australian Network for Plant Conservationc/o Kings Park Botanic GardensFraser AvenueWest Perth 6005WESTERN AUSTRALIATel: +61 8 9480 3637Fax: +61 8 9480 3641Web: www.anbg.gov.au

Senior Contact: Dr Kingsley DixonPosition: Director Plant SciencesEmail: kdixon@kpbg.wa.gov.au

Company OverviewThe Australian Network for Plant Conservation Inc.(ANPC) brings together over 400 members who areinterested in helping to save Australia’s native plantheritage. Members include state and nationalconservation agencies, local government, othergovernment agencies, botanic gardens, zoos, industrygroups, bush regeneration groups, native plant growers,Friends groups, other community groups, researchersand individuals, both in Australia and overseas. The goalof the ANPC is “To promote and develop plantconservation in Australia.”

BioMed Alliance WAGPO Box U1987Perth 6845WESTERN AUSTRALIATel: +61 8 9266 2134Fax: +61 8 9266 7485Web: http://www.wabri.org.au/RDAlliance.html

Senior Contact: Dr Simon HoltbyPosition: Executive OfficerEmail: s.holtby@curtin.edu.au

Company OverviewThe BioMed Alliance is a unique collaboration ofbiomedical research institutes coming together withuniversity, industry and government leaders to developWestern Australia as an internationally recognised BioInnovation Hub.

46

Index

Biotechnology Companies .......................................................................................................... 7 - 35

Advanced Nano Technologies Pty Ltd .................................................................................................................... 7Ag-Id Pty Ltd ............................................................................................................................................................ 7Agri-BIOTECH Pty Ltd ............................................................................................................................................. 7Alzhyme (WA) Pty Ltd ............................................................................................................................................. 8Animal Resources Centre ....................................................................................................................................... 8Aquabiotics Pty Ltd .................................................................................................................................................. 8AquaCarotene Limited ............................................................................................................................................ 8Argus Biomedical Pty Ltd ........................................................................................................................................ 9Artemia Biotechnology Centre Pty Ltd .................................................................................................................... 9Asthma & Allergy Research Institute Inc ................................................................................................................ 9Australian Biosearch ............................................................................................................................................... 9Australian Cancer Technology Ltd ........................................................................................................................ 10Australian Institute of Marine Science (AIMS) ...................................................................................................... 10Australian Neuromuscular Research Institute ...................................................................................................... 10Australian Research Centre for Medical Engineering ...........................................................................................11Bactech (Australia) Pty Ltd .....................................................................................................................................11BioEnergy Australia Pty Ltd ...................................................................................................................................11Bio-Gene Technology Pty Ltd .................................................................................................................................11Biomax Pty Ltd ...................................................................................................................................................... 12BioProspect Ltd ..................................................................................................................................................... 12Biorex Health Ltd ................................................................................................................................................... 12Biotechna_Graesser A.P. Castella Pty Ltd ........................................................................................................... 12Botanic Gardens and Parks Authority (Kings Park) ............................................................................................. 12Canola Breeders Western Australia Pty Ltd ......................................................................................................... 12Centre for Bioinformatics and Biological Computing ............................................................................................ 13Centre for High-throughput Agricultural Genetic Analysis (CHAGA) ................................................................... 13Centre for Human Genetics .................................................................................................................................. 13Centre for Microscopy and Microanalysis ............................................................................................................. 14Centre for Molecular Immunology & Instrumentation ........................................................................................... 14Chemeq Ltd ........................................................................................................................................................... 14Chemistry Centre (WA) ......................................................................................................................................... 14Clinical Cell Culture (C3) Pty Ltd .......................................................................................................................... 14Cognis Nutrition and Health .................................................................................................................................. 15CollTech Australia Pty Ltd ..................................................................................................................................... 15Concept Fertility Centre ........................................................................................................................................ 15Cottman SBA ......................................................................................................................................................... 15CRC for Legumes in Mediterranean Agriculture (CLIMA) .................................................................................... 15CSIRO.................................................................................................................................................................... 15CSIRO - Centre for Mediterranean Agricultural Research ................................................................................... 16CSIRO Land and Water ........................................................................................................................................ 16CSIRO - Livestock Industries - Mediterranean Livestock Systems (MLS) ........................................................... 16CSIRO Minerals - AJ Parker CRC for Hydrometallurgy ....................................................................................... 17CSIRO Petroleum .................................................................................................................................................. 17Curtin University - Department of Environmental Biology .................................................................................... 17Curtin University - School of Biomedical Science ................................................................................................ 18CustomVis (CLVR Pty Ltd) .................................................................................................................................... 18Department of Agriculture ..................................................................................................................................... 18Department of Conservation and Land Management .......................................................................................... 18DNA-ID Labs Pty Ltd ............................................................................................................................................. 18Eastland Medical Systems Limited ....................................................................................................................... 19ENT Technologies Pty Ltd ..................................................................................................................................... 19Environmental Solutions International Ltd ............................................................................................................ 19Environmental Technology Centre ........................................................................................................................ 19EQiTX .................................................................................................................................................................... 19Fisher Biotec Pty Ltd ............................................................................................................................................. 20Fisheries Management Services ........................................................................................................................... 20Fluid System Technologies (WA) .......................................................................................................................... 20FOSS Pacific Pty Ltd ............................................................................................................................................. 21Fremantle Hospital Medical Research Foundation .............................................................................................. 21Gene Stream Pty Ltd ............................................................................................................................................. 21Genesis Biomedical Ltd ........................................................................................................................................ 21Go Medical Industries Pty Ltd ............................................................................................................................... 21

47

Grain Biotech Australia Pty Ltd ............................................................................................................................. 22Gray Surgical ......................................................................................................................................................... 22Ibis Technology ...................................................................................................................................................... 22ID + Plus Ltd .......................................................................................................................................................... 22In Vitro Laboratories Pty Ltd ................................................................................................................................. 22Inner Vision Biometrics Pty Ltd .............................................................................................................................. 22Integra Management Pty Ltd.................................................................................................................................. 23Keogh Institute for Medical Research .................................................................................................................... 23Kestral Computing ................................................................................................................................................. 23Lawley Pharmaceuticals Pty Ltd ............................................................................................................................ 23Lions Cancer Institute (Inc) .................................................................................................................................... 23Lions Ear and Hearing Institute ............................................................................................................................. 24Lions Eye Institute of Western Australia Inc. ......................................................................................................... 24MedicVision Limited ............................................................................................................................................... 24Microgene Pty Ltd .................................................................................................................................................. 24Mount Todd Rehabilitation Project Pty Ltd ............................................................................................................. 25Murdoch University Biotechnology Program.......................................................................................................... 25Newmont Yandal Operations Ltd (Wiluna Operations) .......................................................................................... 25Orion Laboratories Pty Ltd ..................................................................................................................................... 25Ozgene Pty Ltd ...................................................................................................................................................... 25Pacific Ore Technologies Australia Pty Ltd ............................................................................................................ 26Paradigm Diagnostics ............................................................................................................................................ 26Peko Rehabilitation Project Pty Ltd ....................................................................................................................... 26PerkinElmer Life and Analytical Sciences Pty Ltd ................................................................................................. 26Perth Bone and Tissue Bank Inc. .......................................................................................................................... 27Pharmacia Australia Pty Ltd .................................................................................................................................. 27Phylogica Ltd ......................................................................................................................................................... 27ProMicro Pty Ltd .................................................................................................................................................... 27Proteomics International ........................................................................................................................................ 27pSivida Ltd ............................................................................................................................................................. 28Raine Medical Research Foundation .................................................................................................................... 28Rockeby Biomed Limited ....................................................................................................................................... 28Rowe Scientific Pty Ltd .......................................................................................................................................... 28Royal Perth Hospital .............................................................................................................................................. 28Rumen Biotech ...................................................................................................................................................... 29Saturn Biotech Ltd ................................................................................................................................................. 29Solbec Pharmaceuticals Ltd .................................................................................................................................. 29Talon Resources .................................................................................................................................................... 30Telethon Institute for Child Health Research ......................................................................................................... 30Titan Resources NL ............................................................................................................................................... 30Tri-Med Distributors Pty Ltd ................................................................................................................................... 30University of Western Australia, Office of Industry and Innovation ....................................................................... 31University of Western Australia, Department of Anatomy and Human Biology ..................................................... 31University of Western Australia - School of Electrical, Electronic and Computer Engineering -Optical and Biomedical Engineering Laboratory .................................................................................................. 32Urological Research Centre .................................................................................................................................. 32Uropath Pty Ltd & Tissugen Pty Ltd ...................................................................................................................... 32Verigen Australia Pty Ltd ....................................................................................................................................... 32Viaticus Capital Pty Ltd ......................................................................................................................................... 32VibraQ Corporation ............................................................................................................................................... 33VRI Biomedical Limited ......................................................................................................................................... 33WA State Agricultural Biotechnology Centre ........................................................................................................ 33Western Australian Biomedical Research Institute .............................................................................................. 34Western Australian Institute for Medical Research .............................................................................................. 34Women and Infants Research Foundation ........................................................................................................... 35World Waste Solutions .......................................................................................................................................... 35Xcell Diagnostics ................................................................................................................................................... 35

Professional Service Providers .................................................................................................................. 36 - 44Ammtec Ltd ............................................................................................................................................................ 36AtSource Organics Australia Pty Ltd .................................................................................................................... 36Biomedical Investments Ltd .................................................................................................................................. 36Biotechnology International Advisory Services .................................................................................................... 37Centre for Medical and Surgical Skills (CTEC) .................................................................................................... 37Churchill Capital Services Pty Ltd ......................................................................................................................... 37Clayton Utz ............................................................................................................................................................ 37Corrs Chambers Westgarth .................................................................................................................................. 38

48

Doug McGhie and Associates ............................................................................................................................... 38Ernst & Young ........................................................................................................................................................ 39Foundation Capital Ltd .......................................................................................................................................... 39Griffith Hack ........................................................................................................................................................... 39Innovation Research Australia .............................................................................................................................. 40Lakefield Oretest Pty Ltd ....................................................................................................................................... 41Lord and Company ................................................................................................................................................ 41Marketing Edge Agricultural Services ................................................................................................................... 42Mosaic Reputation Management .......................................................................................................................... 42The Oil Mallee Company of Australia Ltd ............................................................................................................. 42Pricewaterhouse Coopers ..................................................................................................................................... 43Symbion Ltd ........................................................................................................................................................... 43TechStart Australia Pty Ltd .................................................................................................................................... 43Tessitura Pty Ltd .................................................................................................................................................... 44Venture Capital Corporation International Pty Ltd ................................................................................................ 44Wray & Associates ................................................................................................................................................ 44

Industry Associations and Interest GroupsAusBiotech - Western Australia (WA) Branch ...................................................................................................... 45Australasian Association of Clinical Biochemists ................................................................................................. 45Australian Network for Plant Conservation ........................................................................................................... 45BioMed Alliance WA .............................................................................................................................................. 45

49

Do you need to update your company details?

To update your company details please complete information below and return to:

Bio Industries BranchDepartment of Industry and ResourcesTel: +61 8 9222 5555Fax: +61 8 9222 5870Email: diana.cameron@doir.wa.gov.au

COMPANY NAME: ________________________________________________________________

ESTABLISHED: ________________________________________________________________

ADDRESS: ________________________________________________________________

________________________________________________________________

SUBURB: ________________________________________________________________

POSTCODE: ________________________________________________________________

STATE: ________________________________________________________________

TEL: ________________________________________________________________

FAX: ________________________________________________________________

EMAIL: ________________________________________________________________

WEB: ________________________________________________________________

COMPANY OVERVIEW: ______________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

PRODUCT INFORMATION: ___________________________________________________________

________________________________________________________________

________________________________________________________________

________________________________________________________________

SENIOR CONTACT:

POSITION: ________________________________________________________________

EMAIL ________________________________________________________________

50

Bio Industries TeamIndustry and Trade DivisionDepartment of Industry and Resources2 Havelock StreetWest PerthWESTERN AUSTRALIA 6005

Tel: (+618) 9222 5555Fax: (+618) 9222 5870Web: www.doir.wa.gov.au

Proud supporter of Technology

Department ofIndustry and Resources

Australia